Unspecified dementia

F5_DEMNAS

obsolete_dementia: ['An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.']

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F03 Hospital discharge: ICD-9 — 290\|2941 Hospital discharge: ICD-8 — 2900\|29019 Cause of death: ICD-10 — F03 Cause of death: ICD-9 — 290\|2941 Cause of death: ICD-8 — 2900\|29019 2 out of 7 registries used, show all original rules.	7491
4. Check minimum number of events None	7491
5. Include endpoints None	7491
6. Filter based on genotype QC (FinnGen only)	6291

Control definitions (FinnGen only)

Control exclude: F5_ORGANIC

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF3
Parent code in ICD-10: F00-F03
Name in latin: Dementia non specificata

NAME	F5_DEMNAS
CONTROL_EXCLUDE	F5_ORGANIC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F03
HD_ICD_9	290\|2941
HD_ICD_8	2900\|29019
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F03
COD_ICD_9	290\|2941
COD_ICD_8	2900\|29019
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Unspecified dementia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	145951	90631	52782
Only index persons	77028	49346	27682
Unadjusted period prevalence (%)
Whole population	2.19	2.60	1.47
Only index persons	1.54	1.81	1.06
Median age at first event (years)
Whole population	81.75	82.82	80.06
Only index persons	82.76	84.12	80.34

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6291	2803	3488
Unadjusted period prevalence (%)	1.33	1.00	1.60
Median age at first event (years)	79.96	80.94	79.17

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6054: Matched controls
54315

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F06.7

ICD-10 Finland

Mild cognitive disorder

10.7

320.2

378

337

G30.0

ICD-10 Finland

Alzheimer disease with early onset

87.9

307.7

199

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

59.7

307.7

433

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

52.4

307.7

974

198

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

151.6

307.7

649

R41.0

ICD-10 Finland

Disorientation, unspecified

7.5

307.7

680

896

N06DX01

ATC

memantine; oral

123.2

307.7

1717

174

F01.9

ICD-10 Finland

Vascular dementia, unspecified

53.3

307.7

431

N06DA02

ATC

donepezil; oral

99.1

307.7

1317

152

G30.1

ICD-10 Finland

Alzheimer disease with late onset

44.1

307.7

1382

362

N06DA04

ATC

galantamine; oral

87.8

307.7

368

F03

ICD-10 Finland

Unspecified dementia

4170.4

307.7

5832

340

N06DA03

ATC

rivastigmine; oral, transdermal

105.7

307.7

843

N05AH04

ATC

quetiapine; oral

6.8

307.7

1573

2672

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

307.7

1155

P20

ICPC

Memory disturbance

4.3

307.7

1721

4570

G30.8

ICD-10 Finland

Other Alzheimer disease

40.9

307.7

529

127

P70

ICPC

Dementia

17.7

307.7

409

222

N05AX08

ATC

risperidone; systemic

17.0

307.7

1880

1405

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

5.7

307.7

1313

2512

F05.9

ICD-10 Finland

Delirium, unspecified

63.6

307.7

398

N03AG01

ATC

valproic acid; systemic, rectal

6.7

306.9

536

778

N05AD01

ATC

haloperidol; systemic

5.9

294.6

584

963

N05AH03

ATC

olanzapine; systemic

7.5

285.5

444

566

SPAT1053

SPAT

Memory test

2.9

257.7

1563

5765

G30

ICD-10 Finland

Alzheimer disease

46.0

249.0

160

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.4

239.5

2751

13808

N05BA04

ATC

oxazepam; oral

2.6

234.9

1960

8463

F05.1

ICD-10 Finland

Delirium superimposed on dementia

371.4

230.4

240

R53

ICD-10 Finland

Malaise and fatigue

2.5

219.0

2016

9067

N05AD03

ATC

melperone; systemic

7.8

209.5

313

379

F0019, G301,

ICD-10 Finland

+∞

209.2

208

WYA20

NOMESCO Finland

Home visit

7.0

197.8

323

433

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

215.7

195.1

209

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.9

178.7

590

1471

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

26.1

174.9

131

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.1

169.9

506

1169

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

+∞

169.7

169

G31.0

ICD-10 Finland

Circumscribed brain atrophy

19.4

169.4

142

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.0

164.3

868

2905

F05.8

ICD-10 Finland

Other delirium

43.1

159.6

104

N05BA06

ATC

lorazepam; systemic, sublingual

3.6

156.7

575

1538

A06AD11

ATC

lactulose; oral

2.2

154.4

1761

8469

N06AX11

ATC

mirtazapine; oral

2.2

154.2

2016

10234

N06AB04

ATC

citalopram; systemic

2.3

149.2

1393

6147

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.6

148.3

552

1489

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

146.3

2664

15220

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

7.1

137.3

219

285

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

167.7

134.1

146

SPAT1234

SPAT

Support of social functional capacity

3.2

132.5

595

1803

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

130.6

1409

6562

Z75.5

ICD-10 Finland

Holiday relief care

6.6

128.7

219

306

F009, G309,

ICD-10 Finland

+∞

128.4

128

A28

ICPC

Limited function/disability NOS

2.0

125.3

1802

9344

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

123.9

1896

10044

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

580.5

123.5

127

N06AB10

ATC

escitalopram; oral

2.6

123.1

842

3197

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

19.8

120.5

100

SPAT1216

SPAT

Assessment of functional ability

2.2

119.7

1354

6398

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

118.9

1447

7031

R41.3

ICD-10 Finland

Other amnesia

4.5

118.3

308

638

F29

ICD-10 Finland

Unspecified nonorganic psychosis

8.2

118.0

166

186

TAB00

NOMESCO Finland

Lumbar puncture

5.1

115.8

257

465

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.1

114.4

1302

6154

F00, F03,

ICD-10 Finland

+∞

114.3

114

SPAT1254

SPAT

Administration of medicine

2.2

113.7

1240

5763

AA1AD

NOMESCO Finland

CT of head and brain

1.9

111.7

2118

11980

F01.2

ICD-10 Finland

Subcortical vascular dementia

27.6

111.6

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

110.8

892

3644

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

110.8

1304

6235

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.3

109.5

448

1278

F00

ICD-10 Finland

Dementia in Alzheimer disease

32.2

101.2

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.9

98.9

529

1762

F22.0

ICD-10 Finland

Delusional disorder

7.6

98.8

148

179

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

189.8

96.4

104

S72.0

ICD-10 Finland

Fracture of neck of femur

2.6

96.3

607

2201

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

54.4

96.2

XA800

NOMESCO Finland

Neuropsychological investigation

5.4

92.7

192

326

N02AA05

ATC

oxycodone; systemic

1.9

90.9

1560

8438

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.8

87.6

284

693

S06.0

ICD-10 Finland

Concussion

2.4

87.2

695

2810

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.2

84.0

353

1021

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

8.6

82.2

111

118

Z02.4

ICD-10 Finland

Examination for driving licence

0.4

80.8

650

11477

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.2

76.8

332

976

W19

ICD-10 Finland

Unspecified fall

2.2

76.4

728

3166

N05AB03

ATC

perphenazine; systemic, rectal

4.0

75.5

226

520

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

75.5

1007

4968

L28

ICPC

Limited function/disability (L)

1.8

74.3

1515

8559

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

5.8

73.6

141

222

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.0

72.3

861

4074

F009, F03,

ICD-10 Finland

+∞

72.1

SPAT1172

SPAT

Guidance concerning hydration

3.2

71.4

309

909

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.8

69.8

386

1303

E86

ICD-10 Finland

Volume depletion

3.1

69.7

308

917

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

68.9

828

3927

S01.0

ICD-10 Finland

Open wound of scalp

2.3

68.4

601

2522

N05AX12

ATC

aripiprazole; systemic

7.5

67.8

102

124

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

25.6

67.7

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

22.8

67.5

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.8

66.9

371

1254

F0009, G300,

ICD-10 Finland

+∞

66.1

J01CA08

ATC

pivmecillinam; oral

1.6

62.2

2056

13099

F01

ICD-10 Finland

Vascular dementia

14.3

62.0

N30.0

ICD-10 Finland

Acute cystitis

1.8

61.0

1038

5512

P29

ICPC

Psychological sympt/compl other

3.7

61.0

204

508

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

551.4

59.3

N06AB06

ATC

sertraline; oral

2.4

57.7

420

1620

SPAT1229

SPAT

Assessment of need for aid

2.1

57.7

631

2881

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.6

56.4

347

1235

N04AA02

ATC

biperiden; systemic

4.9

56.2

129

240

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.1

55.9

251

754

N05AH02

ATC

clozapine; systemic

11.2

55.7

SPAT1279

SPAT

Preparation of immediate hospitalisation

4.0

55.5

165

378

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

55.3

1143

6411

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

95.2

55.2

N05AA02

ATC

levomepromazine; systemic

2.9

54.1

272

871

N06AX26

ATC

vortioxetine; oral

3.0

53.7

252

776

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

4.7

53.7

131

257

R44.1

ICD-10 Finland

Visual hallucinations

7.5

53.3

R44.3

ICD-10 Finland

Hallucinations, unspecified

8.4

52.6

F0029, G308,

ICD-10 Finland

+∞

52.0

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

4.6

51.6

129

258

F01.1

ICD-10 Finland

Multi-infarct dementia

+∞

51.0

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

51.0

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.4

50.3

246

5442

F01.0

ICD-10 Finland

Vascular dementia of acute onset

122.2

48.6

N05CD07

ATC

temazepam; oral

1.7

48.5

1133

6543

N05AN01

ATC

lithium; oral

5.1

48.1

105

187

SPAT1304

SPAT

Counselling and guidance related to ageing

1.9

48.1

685

3420

A10AB05

ATC

insulin aspart; parenteral

2.1

47.8

504

2263

130

Kela drug reimbursment

Malignant tumour

0.3

47.6

148

4074

SPAT1301

SPAT

No procedures

1.5

47.4

1760

11363

Z2445

NOMESCO Finland

Psychologist

4.6

47.3

117

232

R55

ICD-10 Finland

Syncope and collapse

1.8

46.6

862

4662

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

5.4

45.6

159

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.5

45.3

356

6532

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.6

44.7

156

400

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

6.6

44.4

101

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.7

43.3

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

14.8

43.1

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

207.9

43.0

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

10.5

42.3

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.4

42.2

305

1171

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

203.3

42.1

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

42.0

1061

6227

SPAT1101

SPAT

Orthostatic test

2.2

41.9

383

1625

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

73.9

41.8

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

56.5

41.1

A04

ICPC

Weakness/tiredness general

1.7

40.8

962

5544

SPAT1167

SPAT

Insertion of urinary catheter

2.3

40.8

321

1279

SPAT1139

SPAT

Nutrition survey

2.6

40.5

242

848

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

9.0

40.3

SPAT1252

SPAT

Overall medication plan or its review

2.0

40.0

486

2294

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.8

39.9

127

306

A10AE04

ATC

insulin glargine; parenteral

1.9

39.6

598

3034

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.1

39.4

113

252

N02BE01

ATC

paracetamol; systemic, rectal

1.5

38.9

4522

36013

S18

ICPC

Laceration/cut

0.7

38.6

1360

16620

N05AC01

ATC

periciazine; systemic

7.2

38.2

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

79.6

37.9

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

37.3

372

1632

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

7.8

37.2

N05BE01

ATC

buspirone; oral

3.4

36.9

136

362

H02AB02

ATC

dexamethasone; systemic

0.3

36.8

134

3425

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.8

36.8

589

3041

SPAT1251

SPAT

Organisation of medication

2.3

36.7

308

1261

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

9.9

36.5

F0014, G301,

ICD-10 Finland

341.0

36.5

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.6

36.4

213

739

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

36.2

176

553

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.8

36.1

115

277

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.0

36.1

148

J01EA01

ATC

trimethoprim; systemic

1.5

35.8

1625

10815

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.8

35.7

160

N30.9

ICD-10 Finland

Cystitis, unspecified

1.9

35.4

449

2148

N02AJ06

ATC

codeine and paracetamol; systemic

0.6

35.2

864

11468

F21, ,

ICPC

4.0

34.7

101

228

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

34.7

224

816

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

5.9

34.5

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.9

34.3

105

246

P99

ICPC

Psychological disorders other

4.5

34.1

170

N07AA05, ,

ATC

+∞

34.0

N05BA01

ATC

diazepam; systemic, rectal

1.7

33.9

779

4445

SPAT1107

SPAT

Extensive external surface anaesthesia of skin with cream or gel

6.2

33.0

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

9.5

33.0

G72.8

ICD-10 Finland

Other specified myopathies

3.0

32.9

150

455

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

5.2

32.6

123

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.6

32.6

158

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

3.4

32.5

123

333

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

157.9

32.3

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

31.9

395

1873

SPAT1138

SPAT

Guidance concerning bowel function

3.0

31.9

142

425

N05AF05

ATC

zuclopenthixol; systemic

7.1

31.8

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.1

31.6

312

1363

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.1

31.3

335

1508

SPAT1127

SPAT

Enema

3.7

31.3

101

246

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

31.1

535

2817

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

6.8

31.0

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.5

31.0

196

707

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.7

30.9

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.5

30.8

109

283

L82

ICD-10 Finland

Seborrhoeic keratosis

0.5

30.6

342

5630

F10.24

ICD-10 Finland

Alcohol depence active use

5.7

30.5

Z29

ICPC

Social problem NOS

3.1

30.5

134

398

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.5

30.4

192

692

S70.0

ICD-10 Finland

Contusion of hip

2.1

30.2

300

1314

N03AX14

ATC

levetiracetam; systemic

2.8

30.1

156

508

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.1

29.8

128

375

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.7

29.7

563

3045

N05CF01

ATC

zopiclone; oral

1.4

29.7

2132

15299

SPAT1262

SPAT

Handing over of treatment supplies

1.5

29.4

947

5841

F06.0

ICD-10 Finland

Organic hallucinosis

99.2

29.3

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

5.7

29.1

R54

ICD-10 Finland

Senility

3.7

28.7

223

F01.39

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without information on additional symptoms

272.5

28.5

R42

ICD-10 Finland

Dizziness and giddiness

1.4

28.3

1431

9649

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.4

28.2

207

800

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.2

28.1

234

955

N06AX03

ATC

mianserin; oral

2.1

27.8

273

1191

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

11.8

27.7

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

6.8

27.6

L57.0

ICD-10 Finland

Actinic keratosis

0.5

27.6

341

5459

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

263.0

27.6

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

27.6

873

5358

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

27.4

367

1787

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

7.7

27.4

P15

ICPC

Chronic alcohol abuse

3.8

27.3

198

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.9

27.2

115

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.6

27.2

644

3692

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

27.2

455

2374

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

27.1

1678

11705

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.8

27.1

207

G20

ICD-10 Finland

Parkinson disease

2.2

26.8

238

997

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.1

26.5

114

335

G91.0

ICD-10 Finland

Communicating hydrocephalus

5.4

26.3

U04

ICPC

Incontinence urine

1.8

26.1

400

2033

F60.9

ICD-10 Finland

Personality disorder, unspecified

7.9

26.0

188

Kela drug reimbursment

Psychosis requiring demanding treatment

7.9

26.0

R33

ICD-10 Finland

Retention of urine

1.6

25.9

709

4208

N05AC02

ATC

thioridazine; oral

3.3

25.8

101

280

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

7.8

25.6

N06AX16

ATC

venlafaxine; oral

1.8

25.5

382

1926

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

25.5

469

2513

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

6.9

25.5

TQW40, ,

SPAT

0.3

25.4

2143

N03AX09

ATC

lamotrigine; oral

3.1

25.3

108

316

L15

ICPC

Knee symptom/complaint

0.6

25.2

481

6853

A10AE05

ATC

insulin detemir; parenteral

2.0

25.2

299

1397

SPAT1165

SPAT

Peritoneal dialysis

7.4

24.6

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

234.8

24.6

F001, G301,

ICD-10 Finland

121.7

24.5

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.6

24.4

471

6695

R45.1

ICD-10 Finland

Restlessness and agitation

10.1

24.3

P72

ICPC

Schizophrenia

4.6

24.1

113

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

5.6

24.0

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

225.4

23.6

SPAT1263

SPAT

Sampling

1.3

23.5

1929

14005

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

23.5

825

5163

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

6.3

23.5

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.7

23.4

883

10880

SPAT1360

SPAT

Extensive global examination

1.8

23.1

382

1985

R74

ICPC

Upper respiratory infection acute

0.5

22.9

307

4815

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

22.8

171

668

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.2

22.8

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.3

22.7

180

720

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

22.7

734

4512

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.6

22.4

318

4910

N05AL01

ATC

sulpiride; systemic

3.2

22.2

255

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

+∞

22.0

H02AA02

ATC

fludrocortisone; oral

3.5

21.9

204

SPAT1125

SPAT

Stoma care and guidance

2.4

21.8

149

558

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

2.8

21.7

110

355

Z60.8

ICD-10 Finland

Other problems related to social environment

5.9

21.7

SPAT1240

SPAT

Therapeutic discussion

2.0

21.7

237

1076

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.7

21.6

410

2214

A03FA01

ATC

metoclopramide; systemic, rectal

0.7

21.3

621

8072

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

3.5

21.3

199

L08

ICPC

Shoulder symptom/complaint

0.6

21.1

437

6123

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.9

21.0

254

1195

F0011, G301,

ICD-10 Finland

+∞

21.0

N03AX18

ATC

lacosamide; systemic

6.2

20.9

N03AF02

ATC

oxcarbazepine; oral

2.4

20.9

147

558

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.8

20.9

334

1717

H04AA01

ATC

glucagon; nasal, parenteral

3.8

20.9

155

N07BB01

ATC

disulfiram; oral

2.8

20.8

106

343

SPAT1255

SPAT

Intravenous administration of medicine

1.7

20.7

373

1987

EB4VA, ,

NOMESCO Finland

0.3

20.7

1728

N05AF03

ATC

chlorprothixene; systemic

3.0

20.5

282

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

20.4

480

2742

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

7.0

20.4

SPAT1307

SPAT

Psychosocial counselling and guidance

2.6

20.2

115

395

SPAT1062

SPAT

Lung clearance therapy

4.8

20.1

N05BA12

ATC

alprazolam; oral

1.7

19.9

425

2368

TDA90, ,

SPAT

0.4

19.9

1986

N28

ICPC

Limited function/disability (N)

2.7

19.9

105

347

G04BD07

ATC

tolterodine; oral

1.7

19.8

379

2051

A29

ICPC

General symptom/complaint other

1.5

19.8

718

4515

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

7.3

19.7

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.7

19.7

107

359

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.6

19.6

115

401

W06

ICD-10 Finland

Fall involving bed

3.1

19.6

247

L17

ICPC

Foot/toe symptom/complaint

0.7

19.6

760

9361

S06.3

ICD-10 Finland

Focal brain injury

3.0

19.6

266

P05

ICPC

Senility, feeling/behaving old

3.7

19.5

154

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.7

19.5

150

N06AB03

ATC

fluoxetine; oral

1.6

19.5

453

2578

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.4

19.5

184

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

37.5

19.4

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

19.4

391

2147

SDA03

NOMESCO Finland

Periodontal treatment

0.7

19.3

621

7925

Y94.0

ICD-10 Finland

Accident at home

2.5

19.3

128

474

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.7

19.2

747

9203

F01.8

ICD-10 Finland

Other vascular dementia

43.2

19.1

N29

ICPC

Neurological sympt/complt other

2.7

19.1

104

349

F31

ICD-10 Finland

Bipolar affective disorder

6.3

19.1

EB1VA, ,

NOMESCO Finland

0.5

19.0

156

2863

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.4

19.0

183

R11

ICD-10 Finland

Nausea and vomiting

1.6

18.9

482

2805

K86

ICPC

Hypertension uncomplicated

0.6

18.9

343

4971

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

2.0

18.9

201

905

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

18.8

1437

10256

F31.8

ICD-10 Finland

Other bipolar affective disorders

5.8

18.8

K85

ICPC

Elevated blood pressure

0.6

18.7

480

6422

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

18.6

366

1996

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

18.5

771

4974

S32.5

ICD-10 Finland

Fracture of pubis

2.7

18.5

100

335

C04AE01

ATC

ergoloid mesylates; systemic

2.8

18.4

290

GD1AA, ,

SPAT

0.4

18.4

105

2210

N88

ICPC

Epilepsy

5.3

18.3

C10AA07

ATC

rosuvastatin; oral

0.7

18.1

762

9266

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

5.8

18.1

SPAT1153

SPAT

Removal of sutures

0.7

18.0

911

10748

S12

ICPC

Insect bite/sting

0.4

18.0

114

2302

T68

ICD-10 Finland

Hypothermia

4.7

18.0

S00.0

ICD-10 Finland

Superficial injury of scalp

2.2

17.9

155

644

Z03

ICPC

Housing/neighbourhood problem

4.1

17.9

110

M01AH05

ATC

etoricoxib; oral

0.8

17.9

1497

16396

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

5.0

17.9

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

7.0

17.8

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

171.0

17.7

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.6

17.7

152

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

4.7

17.6

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

4.2

17.6

104

C10AX09

ATC

ezetimibe; oral

0.6

17.5

305

4472

A04AA02

ATC

granisetron; systemic, transdermal

0.3

17.5

1437

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

17.5

191

868

J01DB01

ATC

cefalexin; oral

1.3

17.4

3747

30446

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

39.6

17.3

N05AA01

ATC

chlorpromazine; systemic, rectal

3.6

17.3

146

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.3

17.2

131

516

R05

ICPC

Cough

0.7

17.2

508

6611

R01AD58

ATC

fluticasone, combinations; nasal

0.5

17.1

215

3446

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.7

17.1

291

1524

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.7

17.1

303

1606

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

17.1

502

3017

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.9

16.9

115

WX402

NOMESCO Finland

General anaesthesia

0.6

16.7

324

4624

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

16.6

1119

7823

N06AA12

ATC

doxepin; systemic

1.7

16.5

303

1621

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

16.5

541

6898

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.7

16.4

817

9684

S06.2

ICD-10 Finland

Diffuse brain injury

3.4

16.4

156

-2, ,

ICPC

3.3

16.3

165

A10BB12

ATC

glimepiride; oral

1.5

16.3

607

3829

H02AB06

ATC

prednisolone; systemic

0.8

16.3

1890

19922

WW200, ,

SPAT

0.7

16.2

626

7745

S82

ICPC

Naevus/mole

0.6

16.1

210

3329

IGV01

NOMESCO Finland

Psychiatric network contact

7.5

16.1

4378A

ICD-9 Finland

Other and ill-defined cerebrovascular disease, Other[MULTI-INFARKTIDEMENTIA]

+∞

16.0

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

+∞

16.0

F0024, G308,

ICD-10 Finland

+∞

16.0

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

15.9

832

5580

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

19.6

15.8

F02.80

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without additional symptoms

81.0

15.8

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

152.9

15.8

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.0

15.8

177

813

R50.9

ICD-10 Finland

Fever, unspecified

1.4

15.7

744

4906

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

15.6

416

2445

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

4.8

15.6

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

15.4

1448

10590

N06AB05

ATC

paroxetine; oral

2.0

15.4

160

715

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.6

15.4

351

4831

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.4

15.4

1823

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.1

15.4

143

613

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.4

15.3

R1250

NOMESCO Finland

Evaluation of functional capability

2.5

15.3

331

P04

ICPC

Feeling/behaving irritable/angry

7.4

15.3

S29

ICPC

Skin symptom/complaint other

0.7

15.3

481

6189

T93

ICPC

Lipid disorder

0.4

15.1

1699

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.2

15.0

174

P28

ICPC

Limited function/disability (P)

4.2

15.0

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

+∞

15.0

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

15.0

N03AF01

ATC

carbamazepine; oral, rectal

1.7

14.9

302

1662

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

7.1

14.8

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

76.5

14.8

C03CA01

ATC

furosemide; systemic

1.2

14.8

2965

23681

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

143.9

14.8

Z72.1

ICD-10 Finland

Alcohol use

3.8

14.8

106

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.6

14.7

300

AXX01, ,

SPAT

1.9

14.7

190

915

Z28

ICPC

Limited function/disability (Z)

3.7

14.6

111

S21

ICPC

Skin texture symptom/complaint

0.6

14.4

333

4571

N99

ICPC

Neurological disease other

3.0

14.4

198

ZXD10

NOMESCO Finland

Scheduled procedure

0.8

14.3

1367

14823

M25.5

ICD-10 Finland

Pain in joint

0.7

14.3

618

7516

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

2.8

14.3

233

N03AE01

ATC

clonazepam; systemic

1.7

14.3

241

1261

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.7

14.2

277

1507

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

3.3

14.2

148

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

14.0

749

5036

S01.8

ICD-10 Finland

Open wound of other parts of head

2.5

14.0

313

SPAT1243

SPAT

Psychiatric/psychological examination

3.7

14.0

106

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.5

14.0

442

2696

XX3DW

NOMESCO Finland

Time consuming IT work

0.6

14.0

191

2991

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

14.0

242

1275

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

+∞

14.0

F0280, G318,

ICD-10 Finland

+∞

14.0

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

4.0

14.0

R03AC02

ATC

salbutamol; inhalant

0.8

14.0

1768

18557

A69.2

ICD-10 Finland

Lyme disease

0.3

14.0

1212

N06AG02

ATC

moclobemide; oral

1.9

13.9

165

773

R44.0

ICD-10 Finland

Auditory hallucinations

5.2

13.9

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.1

13.9

136

595

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.5

13.8

106

1993

G40

ICD-10 Finland

Epilepsy

4.1

13.8

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.3

13.8

1107

K08.3

ICD-10 Finland

Retained dental root

1.6

13.8

340

1964

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.7

13.5

250

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.6

13.3

238

3471

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

10.2

13.2

Z75.0

ICD-10 Finland

Medical services not available in home

4.4

13.2

A10AD05

ATC

insulin aspart; parenteral

1.9

13.1

178

872

K03.64

ICD-10 Finland

Dental calculus supragingival

0.7

13.1

440

5605

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

13.1

1684

12757

E000001, ,

ATC

1.3

13.0

843

5837

GD1AA

NOMESCO Finland

Thorax X-ray examination

0.8

13.0

1979

20409

SPAT1244

SPAT

Occupational therapy

2.9

13.0

185

WX100

NOMESCO Finland

Conjunctival surface anesthesia

0.7

13.0

459

5791

A86

ICD-10 Finland

Unspecified viral encephalitis

4.5

13.0

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

+∞

13.0

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.7

13.0

222

1167

P27

ICPC

Fear of mental disorder

4.4

12.9

WZC30

NOMESCO Finland

Teaching

0.6

12.9

326

4395

A10BA02

ATC

metformin; oral

1.3

12.9

1648

12473

L03

ICPC

Low back symptom/complaint

0.7

12.9

633

7549

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

0.6

12.9

237

3433

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

125.9

12.9

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.1

12.9

128

564

N06AX21

ATC

duloxetine; oral

1.5

12.8

374

2244

S72.2

ICD-10 Finland

Subtrochanteric fracture

2.4

12.7

312

G40.89

ICD-10 Finland

Other epilepsy

4.7

12.7

H02

ICPC

Hearing complaint

0.7

12.7

465

5828

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

4.9

12.7

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

12.6

1026

7336

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

2.1

12.6

112

473

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.5

12.5

287

WF002

NOMESCO Finland

Radical radiotherapy

0.4

12.5

1544

F34.1

ICD-10 Finland

Dysthymia

2.3

12.5

359

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.0

12.4

128

571

ZYB04, ,

SPAT

4.8

12.4

ZXE00

NOMESCO Finland

One hour or less

0.8

12.3

1305

14032

SPAT1050

SPAT

Extensive neurological examination

2.2

12.3

102

419

JN4BD

NOMESCO Finland

Extensive body CT

0.6

12.2

267

3715

N02AX02

ATC

tramadol; systemic, rectal

0.8

12.2

1682

17562

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

4.5

12.2

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

3.1

12.2

149

G41.9

ICD-10 Finland

Status epilepticus, unspecified

3.6

12.1

100

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

4.4

12.1

S01

ICD-10 Finland

Open wound of head

2.6

12.1

249

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.0

12.1

129

584

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

12.1

975

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.2

12.0

136

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

+∞

12.0

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

2.0

12.0

131

598

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

3.0

12.0

160

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

0.7

11.9

718

8314

ZYY79, ,

SPAT

3.7

11.9

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

116.9

11.9

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.5

11.8

117

2017

JN4AD

NOMESCO Finland

Body CT examination

0.6

11.8

279

3815

A10AC01

ATC

insulin (human); parenteral

1.4

11.8

525

3421

H29

ICPC

Ear symptom/complaint other

0.6

11.7

267

3683

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

11.7

1135

J01MA02

ATC

ciprofloxacin; systemic

1.2

11.7

2152

16899

G93.4

ICD-10 Finland

Encephalopathy, unspecified

5.3

11.6

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.2

11.6

710

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.3

11.6

1088

R32

ICD-10 Finland

Unspecified urinary incontinence

1.8

11.5

161

797

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

11.5

460

2940

Z51.5

ICD-10 Finland

Palliative care

1.4

11.5

613

4118

P76

ICPC

Depressive disorder

2.0

11.5

115

509

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.6

11.4

210

3041

D82

ICPC

Teeth/gum disease

0.7

11.4

597

7059

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

2.7

11.3

205

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.9

11.3

170

F01.21

ICD-10 Finland

Subcortical vascular dementia without additional symptoms, mainly paranoidism

41.9

11.3

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.1

11.3

137

XA400

NOMESCO Finland

EEG

3.8

11.3

D19

ICPC

Teeth/gum symptom/complaint

0.7

11.3

471

5775

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.8

11.2

715

8220

J96.1

ICD-10 Finland

Chronic respiratory failure

0.4

11.2

1189

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.4

11.2

106

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.4

11.1

1082

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.9

11.1

162

H13

ICPC

Plugged feeling ear

0.7

11.1

642

7485

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.4

11.1

1336

29580

ICD-8 Finland

Schizophrenia, Other

4.7

11.1

SPAT1241

SPAT

Extensive assessment of psychosocial situation

4.7

11.1

AA400

NOMESCO Finland

Electroconvulsive therapy

5.0

11.1

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.4

11.1

266

A10BH05

ATC

linagliptin; oral

1.5

11.1

337

2041

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

11.1

219

1199

F01.89

ICD-10 Finland

Other specified vascular dementia without information on additional symptoms

58.4

11.1

N05BA02

ATC

chlordiazepoxide; systemic

2.1

11.0

109

480

F0021, G308,

ICD-10 Finland

+∞

11.0

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

+∞

11.0

WZC00

NOMESCO Finland

Treatment plan or consultation

0.8

10.9

923

10224

E87.6

ICD-10 Finland

Hypokalaemia

1.7

10.9

192

1018

A04AA01

ATC

ondansetron; systemic, rectal

0.5

10.9

134

2162

Z74.2

ICD-10 Finland

Need for assistance at home and no other household member able to render care

14.7

10.9

F02.09

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

107.9

10.9

F01.84

ICD-10 Finland

Other specified vascular dementia other mixed symptoms of mixed type

107.9

10.9

F01.14

ICD-10 Finland

Multi-infarct dementia's other mixed symptoms of mixed type

107.9

10.9

H81

ICPC

Excessive ear wax

0.7

10.9

621

7257

M70.6

ICD-10 Finland

Trochanteric bursitis

0.7

10.8

290

3865

R06.0

ICD-10 Finland

Dyspnoea

0.8

10.8

1111

12023

DFF00

NOMESCO Finland

Pure tone audiometry

0.6

10.8

248

3416

GD1QA, ,

SPAT

4.9

10.8

ZY000

NOMESCO Finland

Hospital inpatient

3.8

10.7

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

0.3

10.7

967

D06BB10

ATC

imiquimod; topical

0.5

10.5

1638

L01

ICPC

Neck symptom/complaint

0.6

10.5

260

3522

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

15.3

10.5

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.7

10.4

310

4045

SPAT1284

SPAT

Extensive health certificate

2.1

10.4

418

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

10.4

438

2826

F07.2

ICD-10 Finland

Postconcussional syndrome

38.9

10.4

ICB01, ,

SPAT

4.4

10.4

OAB43, ,

SPAT

0.2

10.3

672

TFP20

NOMESCO Finland

Cardiodefibrillation

0.6

10.3

208

2948

L13

ICPC

Hip symptom/complaint

0.7

10.3

531

6301

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.2

10.3

412

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.3

10.2

304

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

12.5

10.2

V613A

ICD-9 Finland

Other family circumstances, Problems with aged parents or in-laws

25.2

10.1

F20.0

ICD-10 Finland

Paranoid schizophrenia

4.8

10.1

K05.30

ICD-10 Finland

Periodontitis complex

0.7

10.1

255

3440

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

10.1

384

2432

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

10.7

10.1

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.1

10.1

382

K80

ICPC

Cardiac arrhythmia NOS

0.6

10.0

164

2446

J01FA09

ATC

clarithromycin; systemic

0.8

10.0

665

7609

N06AB08

ATC

fluvoxamine; oral

2.1

10.0

371

OAB42, ,

SPAT

0.6

10.0

165

2455

F0013, G301,

ICD-10 Finland

+∞

10.0

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

+∞

10.0

F07.0

ICD-10 Finland

Organic personality disorder

+∞

10.0

2941A

ICD-9 Finland

Other organic psychotic conditions (chronic), Dementia in conditions classified elsewhere

+∞

10.0

P98

ICPC

Psychosis NOS/other

9.5

10.0

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.2

10.0

354

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.9

10.0

121

574

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

98.9

10.0

S42.0

ICD-10 Finland

Fracture of clavicle

2.0

9.9

113

524

N18

ICPC

Paralysis/weakness

2.0

9.9

111

512

L03AA02

ATC

filgrastim; parenteral

0.2

9.9

653

J01FA10

ATC

azithromycin; systemic

0.8

9.9

1377

14438

Z11

ICPC

Compliance/being ill problem

3.0

9.9

129

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.3

9.8

737

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.3

9.8

R4135

NOMESCO Finland

Rehabilitation for hearing problems

1.7

9.8

159

826

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.5

9.8

329

2035

P16

ICPC

Acute alcohol abuse

3.3

9.7

102

C61

ICD-10 Finland

Malignant neoplasm of prostate

0.7

9.7

443

5362

N06AX12

ATC

bupropion; oral

2.2

9.7

346

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

8.2

9.7

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

9.7

102

461

IHZ08, ,

SPAT

4.1

9.7

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

2.4

9.6

245

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

9.6

227

1300

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.3

9.6

823

K59.0

ICD-10 Finland

Constipation

1.5

9.6

353

2223

K90

ICPC

Stroke/cerebrovascular accident

1.7

9.5

189

1037

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.0

9.5

127

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.1

9.5

361

R01AD12

ATC

fluticasone furoate; nasal

0.7

9.5

420

5109

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.8

9.5

L01BC06

ATC

capecitabine; oral

0.4

9.5

938

C10AA05

ATC

atorvastatin; oral

0.8

9.5

1703

17434

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.8

9.5

144

734

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.5

9.5

1472

Z2221

NOMESCO Finland

Medical doctor

0.8

9.5

826

9129

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.8

9.4

746

8348

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.5

9.4

1434

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

0.7

9.4

376

4651

R02

ICPC

Shortness of breath/dyspnoea

0.7

9.4

410

4998

SPAT1260

SPAT

Consultation of another employee

1.3

9.4

738

5243

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

5.3

9.4

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

5.3

9.4

WX404

NOMESCO Finland

Intravenous generell anesthesy

0.7

9.3

405

4940

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

4.2

9.3

F60.7

ICD-10 Finland

Dependent personality disorder

8.2

9.2

SPAT1235

SPAT

Mental health, emotional support

4.6

9.2

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.8

9.2

139

707

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

9.2

530

3602

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

0.7

9.2

429

5173

F25

ICD-10 Finland

Schizoaffective disorders

49.4

9.2

F002, G308,

ICD-10 Finland

49.4

9.2

L90

ICPC

Osteoarthrosis of knee

0.6

9.2

125

1955

PJA12

NOMESCO Finland

Sentinel node biopsy

0.5

9.2

100

1668

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.4

9.2

365

2332

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

9.2

242

1423

Z43.5

ICD-10 Finland

Attention to cystostomy

2.6

9.1

186

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.2

9.1

320

N06AA09

ATC

amitriptyline; systemic

1.4

9.1

450

2984

L12

ICPC

Hand/finger symptom/complaint

0.7

9.1

322

4068

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.6

9.1

205

1163

N04BD01

ATC

selegiline; oral

2.1

9.0

351

F02.8

ICD-10 Finland

Dementia in other specified diseases classified elsewhere

+∞

9.0

29000

ICD-8 Finland

Senile and presenile dementia, Senile dementia

+∞

9.0

F0289, G318,

ICD-10 Finland

+∞

9.0

N07AA06, ,

ATC

+∞

9.0

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

89.9

9.0

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

89.9

9.0

R21

ICPC

Throat symptom/complaint

0.6

9.0

217

2953

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.6

8.9

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

8.9

398

2594

N06AA06

ATC

trimipramine; systemic

2.0

8.9

413

SPAT1276

SPAT

Outlining of treatment with patient or their family members

1.8

8.9

126

629

R03AK07

ATC

formoterol and budesonide; inhalant

0.7

8.9

409

4944

183

Kela drug reimbursment

Lamotrigin and topiramate

3.8

8.9

IGY02, ,

SPAT

4.0

8.9

F61.0

ICD-10 Finland

Mixed personality disorders

4.0

8.9

SPAT1014

SPAT

Treatment of eyes

1.9

8.8

107

508

I49.3

ICD-10 Finland

Ventricular premature depolarization

0.6

8.8

128

1967

SPAT1211

SPAT

Application of soft bandage

1.4

8.8

404

2646

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

2.8

8.8

133

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

7.5

8.8

R05

ICD-10 Finland

Cough

0.7

8.8

512

5970

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

8.8

452

3019

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.7

8.7

149

P18

ICPC

Medication abuse

3.9

8.7

F10.7

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Residual and late-onset psychotic disorder

9.6

8.6

N02BF01

ATC

gabapentin; oral

0.6

8.6

162

2330

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.8

8.6

117

578

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

0.5

8.6

1563

F06.4

ICD-10 Finland

Organic anxiety disorder

33.0

8.6

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

1.7

8.5

153

818

M03BX02

ATC

tizanidine; oral

0.8

8.5

1549

15881

N05AF01

ATC

flupentixol; systemic

2.2

8.5

288

EBA30

NOMESCO Finland

Extraction of root of tooth

1.5

8.5

241

1440

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

1.8

8.5

118

586

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

2.0

8.5

366

RT150, ,

NOMESCO Finland

14.0

8.5

B01AC07

ATC

dipyridamole; systemic

1.3

8.4

523

3594

N03AB02

ATC

phenytoin; systemic

2.1

8.4

331

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.5

8.4

ICB03, ,

SPAT

16.7

8.4

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.7

8.4

138

721

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

1.8

8.3

126

642

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.3

8.3

765

F20.5

ICD-10 Finland

Residual schizophrenia

3.8

8.3

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

8.3

162

887

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.3

8.3

640

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.2

8.3

286

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

0.3

8.2

721

SCA02

NOMESCO Finland

Preventive oral health care

1.5

8.2

251

1525

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.5

8.2

29570

ICD-8 Finland

Schizophrenia, Schizo-affective type

6.7

8.2

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.1

8.1

100

A10AE06

ATC

insulin degludec; parenteral

1.9

8.1

453

LAITO, ,

NOMESCO Finland

7.7

8.1

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

4.1

8.1

S01.3

ICD-10 Finland

Open wound of ear

2.3

8.1

231

S08

ICPC

Skin colour change

0.5

8.1

1524

G04AA01, ,

ATC

2.0

8.1

379

M04AA01

ATC

allopurinol; systemic

0.8

8.1

696

7716

F02.84

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere as other mixed symptoms of mixed type

80.9

8.0

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

24.7

8.0

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

1.8

8.0

114

571

F009, G301,

ICD-10 Finland

+∞

8.0

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

+∞

8.0

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

10.4

8.0

E46

ICD-10 Finland

Unspecified protein-energy malnutrition

4.4

7.9

SPAT1313

SPAT

Guidance and counselling related to accident prevention

2.8

7.9

121

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.6

7.9

103

1629

A10BD07

ATC

metformin and sitagliptin; systemic

1.6

7.9

172

969

OAB76

NOMESCO Finland

General guidance on nutrition and food

11.4

7.8

N06AA04

ATC

clomipramine; systemic

2.3

7.8

235

SGB30

NOMESCO Finland

Other complicated root filling

0.4

7.8

932

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.7

7.8

254

3254

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.7

7.7

139

745

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.8

7.7

535

6098

NG1AA, ,

SPAT

0.4

7.7

710

116

Kela drug reimbursment

Prostate cancer

0.7

7.7

280

3520

R40.2

ICD-10 Finland

Coma, unspecified

2.2

7.7

242

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

3.8

7.7

R03BB01

ATC

ipratropium bromide; inhalant

0.7

7.7

219

2881

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.5

7.7

170

N06AX18

ATC

reboxetine; oral

3.0

7.6

R03AK03

ATC

[U] fenoterol and ipratropium bromide

0.7

7.6

336

4091

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

7.6

1297

10028

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.2

7.6

468

G04BD08

ATC

solifenacin; oral

1.4

7.6

350

2295

R12

ICD-10 Finland

Heartburn

0.6

7.6

114

1735

R4110, ,

SPAT

0.7

7.6

257

3273

F01.80

ICD-10 Finland

Other specified vascular dementia without additional symptoms

15.4

7.6

A97

ICPC

No disease

0.8

7.6

517

5906

A10AB04

ATC

insulin lispro; parenteral

1.8

7.6

101

496

SFA20

NOMESCO Finland

Two-surface restoration

0.8

7.6

1249

12947

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

0.7

7.6

271

3416

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

7.6

1229

9460

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

19.8

7.6

ZY010

NOMESCO Finland

Hospital outpatient

1.8

7.6

113

575

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.8

7.5

620

6916

R01AD59

ATC

mometasone, combinations; nasal

0.3

7.5

537

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.4

7.5

830

250, ,

Kela drug reimbursment

0.3

7.5

659

A10BK01

ATC

dapagliflozin; oral

0.6

7.4

144

2057

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

0.7

7.4

295

3654

Z60.2

ICD-10 Finland

Living alone

9.0

7.4

WX408

NOMESCO Finland

General anesthesy, balanced

0.8

7.4

688

7569

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

0.7

7.4

336

4073

Y94.1

ICD-10 Finland

Accident in connection with service housing

8.0

7.4

WZC30, ,

SPAT

0.6

7.4

130

1899

ZXE20

NOMESCO Finland

More than three and less than five hours

0.7

7.4

398

4698

A10BB01

ATC

glibenclamide; oral

1.3

7.4

484

3353

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

4.5

7.4

R01AD09

ATC

mometasone; nasal

0.8

7.3

1018

10730

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

7.3

161

909

R26

ICD-10 Finland

Abnormalities of gait and mobility

4.3

7.3

SPAT1265

SPAT

Breathalyser

3.8

7.3

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.3

7.3

555

Z08

ICPC

Social welfare problem

2.4

7.2

175

A10BH01

ATC

sitagliptin; oral

1.3

7.2

458

3157

M79.6

ICD-10 Finland

Pain in limb

0.8

7.2

1279

13183

S82.5

ICD-10 Finland

Fracture of medial malleolus

2.3

7.2

203

Y77

ICPC

Malignant neoplasm prostate

0.5

7.2

1206

E0000UV, ,

ATC

1.2

7.2

1702

13535

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.7

7.2

362

4317

L02BG04

ATC

letrozole; oral

0.5

7.2

1379

S82.3

ICD-10 Finland

Fracture of lower end of tibia

2.1

7.2

285

DAX08

NOMESCO Finland

Fitting of hearing aid

0.7

7.2

179

2417

H02.3

ICD-10 Finland

Blepharochalasis

0.6

7.2

130

1885

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

1.9

7.2

396

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

0.3

7.2

507

F10.6

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Amnesic syndrome

16.5

7.1

R47.0

ICD-10 Finland

Dysphasia and aphasia

2.0

7.1

328

ACC51

NOMESCO Finland

Release of median nerve

0.6

7.1

107

1624

F01.22

ICD-10 Finland

Subcortical vascular dementia with additional symptoms, mainly hallucinations

71.9

7.1

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

71.9

7.1

F0022, G308,

ICD-10 Finland

71.9

7.1

S44

ICPC

Skin, Preventive immunization/medic

0.2

7.0

271

F0004, G300,

ICD-10 Finland

+∞

7.0

2930A

ICD-9 Finland

Transient organic psychotic conditions, Acute delirium

+∞

7.0

F01.11

ICD-10 Finland

The other additional symptoms of multi-infarct dementia, mainly paranoidism

+∞

7.0

F0012, G301,

ICD-10 Finland

+∞

7.0

F009, G308,

ICD-10 Finland

+∞

7.0

NFJ50

NOMESCO Finland

Internal fixation of fracture of neck of femur with nail or screw

2.4

7.0

178

AXX01

NOMESCO Finland

Memory assessment

3.6

7.0

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.8

7.0

108

556

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

7.0

324

HA1RA, ,

SPAT

0.3

7.0

484

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.2

7.0

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

0.2

7.0

325

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

6.9

1849

14840

I95.9

ICD-10 Finland

Hypotension, unspecified

1.8

6.9

465

N05AB02

ATC

fluphenazine; systemic

2.7

6.9

115

AAF00

NOMESCO Finland

Ventriculostomy

2.8

6.9

105

XF402

NOMESCO Finland

ECG with work load test

0.7

6.9

292

3579

I48.1

ICD-10 Finland

Persistent atrial fibrillation

0.6

6.9

129

1857

L04

ICPC

Chest symptom/complaint

0.6

6.9

1420

ZXC50

NOMESCO Finland

Cryotherapy

0.5

6.9

1282

L03AA13

ATC

pegfilgrastim; parenteral

0.4

6.9

776

B01AF01

ATC

rivaroxaban; oral

0.7

6.9

389

4562

L02BB03

ATC

bicalutamide; oral

0.6

6.9

109

1634

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.7

6.9

266

3306

F32

ICD-10 Finland

Depressive episode

1.8

6.8

104

533

H25.8

ICD-10 Finland

Other senile cataract

1.2

6.8

872

6549

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

0.1

6.8

250

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

6.8

326

2153

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

9.7

6.8

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

3.1

6.8

IEV99, ,

SPAT

26.9

6.8

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

7.5

6.7

F30.9

ICD-10 Finland

Manic episode, unspecified

7.5

6.7

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

2.2

6.7

221

D06

ICPC

Abdominal pain localized other

0.6

6.7

130

1856

G04BD09

ATC

trospium; oral

1.6

6.7

134

739

S06.8

ICD-10 Finland

Other intracranial injuries

4.4

6.7

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.2

6.7

445

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

0.6

6.7

1374

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

3.8

6.7

IHZ01, ,

SPAT

4.0

6.7

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

6.7

414

2846

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.6

6.7

1291

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

0.7

6.7

354

4187

N06AX05

ATC

trazodone; oral

2.0

6.6

325

H01

ICPC

Ear pain/earache

0.6

6.6

146

2021

163

Kela drug reimbursment

Abiraterone and enzalutamide

0.2

6.6

332

S20.8

ICD-10 Finland

Superficial injury of other and unspecified parts of thorax

3.3

6.6

JN1AE, ,

SPAT

0.1

6.6

221

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.1

6.6

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.1

6.6

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.6

6.6

162

942

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.5

6.5

177

1050

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

0.7

6.5

276

3382

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

7.1

6.5

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

6.5

230

F29

ICPC

Eye symptom/complaint other

0.7

6.5

176

2335

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.5

6.5

135

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.8

6.5

104

S01.7

ICD-10 Finland

Multiple open wounds of head

2.8

6.5

104

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

5.9

6.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.3

6.5

560

S50.0

ICD-10 Finland

Contusion of elbow

1.9

6.5

391

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.4

6.5

804

K02.0

ICD-10 Finland

Caries limited to enamel

0.7

6.5

188

2459

SFA30

NOMESCO Finland

Three-surface restoration

0.8

6.5

903

9523

F25.0

ICD-10 Finland

Schizoaffective disorder, manic type

12.4

6.4

H3603, E103,

ICD-10 Finland

3.5

6.4

HA1AA

NOMESCO Finland

X-ray mammography

0.6

6.4

113

1648

G56.0

ICD-10 Finland

Carpal tunnel syndrome

0.7

6.4

268

3289

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.2

6.4

431

R03BA08

ATC

ciclesonide; inhalant

0.6

6.4

120

1723

P01

ICPC

Feeling anxious/nervous/tense

1.6

6.4

145

828

R45.5

ICD-10 Finland

Hostility

15.0

6.3

NA3BG, ,

SPAT

0.2

6.3

399

S09.9

ICD-10 Finland

Unspecified injury of head

1.9

6.3

337

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

2.1

6.3

245

M76.6

ICD-10 Finland

Achilles tendinitis

0.4

6.3

797

Z01.2

ICD-10 Finland

Dental examination

0.8

6.3

959

10037

F01.23

ICD-10 Finland

Subcortical vascular dementia other additional symptoms, mainly depression

20.2

6.3

F10.79

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol UNS

20.2

6.3

AA1XD

NOMESCO Finland

Other special CT of head and brain

3.2

6.3

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

7.4

6.3

Z74.8

ICD-10 Finland

Other problems related to care-provider dependency

8.3

6.3

-44

ICPC

Preventive immunization/medic

0.7

6.3

236

2947

TQW99

NOMESCO Finland

Other minor procedure on skin

0.6

6.3

139

1922

H02AB07

ATC

prednisone; oral

0.8

6.3

506

5662

R96

ICPC

Asthma

0.7

6.3

188

2445

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

0.8

6.3

1299

13236

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

0.8

6.3

354

4149

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.6

6.2

127

ZX090

NOMESCO Finland

Other technic of radiotherapy

0.4

6.2

680

I48.2

ICD-10 Finland

Chronic atrial fibrillation

0.7

6.2

152

2059

HAB40

NOMESCO Finland

Wedge excision of mammary gland

0.5

6.2

1009

H84

ICPC

Presbyacusis

0.6

6.2

137

1896

EP1AE

NOMESCO Finland

Neck ultrasound examination

0.6

6.2

1377

K91

ICPC

Cerebrovascular disease

1.8

6.2

397

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.2

6.2

286

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

63.0

6.1

D07AA02

ATC

hydrocortisone; topical

1.3

6.1

515

3689

N19

ICPC

Speech disorder

2.0

6.1

285

G24.9

ICD-10 Finland

Dystonia, unspecified

4.2

6.1

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

1.7

6.1

112

606

30041

ICD-8 Finland

Neuroses, Depressiva

1.9

6.1

367

M17.1

ICD-10 Finland

Other primary gonarthrosis

0.8

6.1

774

8240

L75

ICPC

Fracture: femur

1.8

6.1

479

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

2.2

6.0

208

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.8

6.0

723

7745

R03BA02

ATC

budesonide; inhalant

0.8

6.0

495

5526

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

198

20.15

239.25

1.0

326.46

234.76

ng/l

3.34

160

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

198

20.15

239.25

1.0

43.51

29.68

ng/l

3.80

156

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

197

20.04

237.53

1.0

650.87

793.24

ng/l

2.06

153

(3009466) Valproate [Moles/volume] in Serum or Plasma

227

275

7.66

151.54

5.0

3.6

339.38

329.89

umol/l

0.35

191

225

(3019309) Folate [Moles/volume] in Red Blood Cells

1845

9121

2.17

150.28

2.0

1.8

1147.97

1137.54

nmol/l

0.16

1442

6703

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

279

541

4.80

116.08

1.2

610.59

651.06

mg/l

0.16

263

526

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

251

444

5.25

115.98

1.4

1.3

334.56

903.06

e6/l

1.03

217

358

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

248

440

5.23

114.21

1.2

1.3

3.29

51.33

e6/l

1.86

206

335

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

253

464

5.06

112.25

1.2

4.16

3.86

mmol/l

2.68

240

432

(1761482) Bacteria [#/volume] in Urine by Culture

479

1466

3.10

104.16

6.5

4.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

623

11373

0.43

85.47

1.7

1.9

1.32

1.25

mmol/l

1.26

540

9134

(3026008) Bacteria identified in Urine by Culture

2385

14916

1.72

83.64

4.7

3.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1591

8932

1.81

80.73

1.9

1.8

424.22

17904062.01

pmol/l

3.83

1286

6993

(3027273) Bicarbonate [Moles/volume] in Venous blood

611

2556

2.27

70.16

3.9

3.5

25.20

24.97

mmol/l

0.70

598

2476

(40768804) Tissue Pathology biopsy report

944

13838

0.54

63.71

2.1

2.5

—

(3000330) Specific gravity of Urine by Test strip

581

2497

2.20

62.20

6.0

4.2

1.02

ratio

6.08

544

2255

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

562

2573

2.06

50.72

1.6

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

649

3156

1.95

49.37

3.7

3.2

126.09

124.47

g/l

1.29

638

3060

(3023183) Ammonium ion [Moles/volume] in Plasma

235

753

2.87

46.68

2.2

2.1

26.95

33.92

umol/l

4.95

195

644

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2078

13958

1.51

46.28

6.5

4.9

0.30

0.84

estimate

0.78

521

3455

(3012516) Albumin [Mass/volume] in Urine

1003

13302

0.61

42.21

3.0

3.4

74.54

55.32

mg/l

1.08

687

8792

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1912

12884

1.48

40.65

2.6

2.2

282.87

214.16

u/l

2.80

1796

12058

(3009508) Creatinine [Moles/volume] in Urine

1021

13335

0.62

39.69

3.0

3.4

6.64

6.60

mmol/l

0.13

835

10871

(3024354) Oxygen [Partial pressure] in Venous blood

800

4433

1.71

39.23

3.5

3.0

4.00

4.33

kpa

8.11

777

4279

(3023368) Bacteria identified in Blood by Culture

2066

14215

1.46

39.13

4.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1474

9569

1.50

36.95

6.1

4.4

0.11

0.53

estimate

1.59

429

3265

(3007930) Methemoglobin/Hemoglobin.total in Blood

437

2079

1.95

35.06

3.8

4.4

0.83

0.85

0.52

423

1970

(3006270) Folate [Moles/volume] in Blood

141

401

3.21

34.44

1.3

1.2

292.92

313.24

nmol/l

0.46

296

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

462

2254

1.91

34.38

3.8

4.3

1.44

1.51

1.37

449

2143

(3021447) Carbon dioxide [Partial pressure] in Venous blood

893

5358

1.58

31.48

3.6

3.5

5.84

5.82

kpa

0.21

867

5187

(3012544) pH of Venous blood

896

5403

1.57

30.86

3.6

3.5

7.38

1.61

652

3269

(3002256) Pathology report gross observation

297

5108

0.50

30.41

1.3

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

371

1751

1.96

30.40

1.9

1.5

1.66

1.64

0.20

302

1403

(3002032) Base excess in Venous blood by calculation

869

5233

1.57

30.05

3.6

3.5

2.11

1.77

mmol/l

2.05

748

4450

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2346

17125

1.37

29.32

5.8

5.0

89.86

97.08

ng/l

0.07

1989

14173

(3019150) Specific gravity of Urine by Refractometry

1263

8314

1.46

28.41

5.7

5.0

1.02

1.19

kg/l

0.50

890

5741

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

145

484

2.73

26.77

2.6

2.2

1.36

1.47

u/field

0.15

237

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

267

3.23

23.76

2.4

2.3

—

(3023410) Appearance of Cerebral spinal fluid

195

3.62

23.36

1.5

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1728

12350

1.36

23.33

2.6

406.81

62.60

u/l

0.48

1610

11341

(3051387) C reactive protein [Mass/volume] in Capillary blood

224

971

2.11

23.18

4.1

3.8

33.06

29.82

mg/l

0.63

184

709

(3022621) pH of Urine by Test strip

532

3038

1.63

22.67

5.6

3.4

6.14

6.06

1.41

437

2206

(3035350) Ketones [Presence] in Urine by Test strip

2525

19140

1.31

22.55

6.2

4.7

1.70

3.87

estimate

0.54

677

4471

(3020682) Albumin/Creatinine [Ratio] in Urine

1181

13752

0.71

22.49

3.7

4.1

16.51

10.30

mg/mmol

1.40

809

8734

(3009261) Glucose [Presence] in Urine by Test strip

2536

19263

1.31

22.19

6.2

4.7

0.06

0.49

estimate

0.68

629

4216

(3026782) Osmolality of Urine

1332

9215

1.38

21.82

4.3

3.3

545.84

521.30

mosm/kgh2o

4.55

1220

8062

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2859

29216

0.77

21.50

4.3

5.2

1.38

1.43

mmol/l

5.43

2470

25853

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

4.75

21.42

1.3

1.2

35.00

71.69

—

(3021601) Nitrite [Presence] in Urine by Test strip

2485

18893

1.31

21.31

6.2

4.7

0.00

estimate

0.50

640

4288

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2775

21446

1.30

20.90

6.6

7.1

1.22

1.21

mmol/l

9.45

2353

18205

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

254

3.10

20.50

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

614

3718

1.54

20.27

3.2

2.6

0.48

0.58

e6/l

0.59

608

3605

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2910

29547

0.78

20.10

4.4

5.3

4.22

4.27

mmol/l

1.90

2539

26420

(3006653) Thiamine [Moles/volume] in Blood

130

3.96

19.46

1.1

1.0

134.88

138.56

nmol/l

0.18

130

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3023

30483

0.78

19.35

4.8

6.2

2.36

2.40

mmol/l

1.87

2637

27133

(4035726) Immunohistochemistry procedure

208

3489

0.52

19.32

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

150

596

2.29

19.29

1.1

1.3

—

(3015736) pH of Urine

2059

15417

1.30

19.21

5.1

4.1

6.44

6.33

5.40

1279

8234

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

319

4625

0.60

17.52

1.3

8.39

15.44

u/ml

1.54

116

1499

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

347

4925

0.61

17.46

1.3

49.52

43.50

iu/ml

0.24

105

1505

(3031040) Bacteria [#/volume] in Urine by Automated count

3207

25582

1.27

17.35

7.2

5.9

4378.03

1910.07

e6/l

1.14

431

(4027681) Cerebrospinal fluid IgG ratio and IgG index

4.82

17.05

1.1

1.2

0.47

ratio

0.00

(3033658) Prothrombin time (PT) actual/Normal

839

9928

0.72

16.74

4.2

79.77

79.43

0.14

812

9719

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2403

18589

1.26

16.57

2.6

2.3

89.82

92.90

pmol/l

2.70

1482

9720

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

310

1675

1.70

16.32

2.3

2.1

760.90

607.04

ug/l

0.30

290

1599

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2791

28129

0.80

16.29

3.9

4.5

1.30

1.24

mmol/l

4.22

2391

24548

(40758558) Short blood count panel - Blood

920

10668

0.73

16.02

6.8

6.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

216

2.97

15.68

1.1

—

3.74

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2033

15570

1.26

14.79

2.3

2.4

75.72

81.21

nmol/l

13.59

1744

13384

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

4.03

14.77

2.0

2.3

63.05

46.43

umol/l

2.07

(3014051) Protein [Presence] in Urine by Test strip

1300

9430

1.30

14.62

5.7

3.8

0.07

0.09

178

436

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

576

3691

1.44

14.22

1.8

1.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

123

3.52

14.00

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

173

3.08

13.92

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

259

2.65

13.67

1.3

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1690

12761

1.26

13.63

2.0

1.8

18.39

19.85

nmol/l

3.06

1483

10636

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

130

566

2.08

13.45

1.3

0.81

0.82

nmol/l

0.04

103

456

(3015377) Calcium [Moles/volume] in Serum or Plasma

1800

13711

1.25

13.42

2.4

3.4

2.34

2.35

mmol/l

2.47

1580

12068

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

307

1743

1.61

13.36

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

5.57

13.35

2.0

1.1

—

(3022145) Colonoscopy Study observation

260

3701

0.61

13.13

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

120

3.46

13.08

1.1

255.97

322.29

mg/l

2.08

103

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

125

3.39

12.98

1.1

33.78

45.22

mg/l

1.96

104

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1203

8763

1.29

12.90

2.1

2.0

—

(3000492) Spirometry study

148

2423

0.54

12.66

1.5

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

1474

11049

1.26

12.45

5.4

4.7

0.00

estimate

1.15

441

3744

(3013826) Glucose [Moles/volume] in Serum or Plasma

2888

23318

1.21

11.88

5.6

5.1

7.38

6.95

mmol/l

14.27

2768

22252

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

316

1866

1.55

11.65

2.1

1.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

545

3592

1.40

11.44

3.2

4.0

1.23

1.22

mmol/l

0.94

447

3082

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1785

13774

1.23

11.42

2.7

2.2

—

(40768797) Stomach Pathology biopsy report

378

4831

0.68

11.42

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

333

2017

1.51

10.93

2.3

2.0

—

(3011288) Drugs identified in Urine by Screen method Nominal

4.42

10.75

2.0

1.3

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3060

29894

0.83

10.52

25.1

23.0

65.99

65.70

ml/min/173m2

0.32

2859

28168

(3014271) Vancomycin [Susceptibility]

358

2.20

10.48

3.5

3.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

148

2.93

10.48

1.4

1.2

1.11

1.01

promille

0.20

112

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

148

2.93

10.48

1.1

—

(21494755) Public health laboratory ask at order entry panel

379

0.14

10.45

1.3

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

155

2353

0.58

10.15

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

125

3.03

9.77

1.5

1.4

123.91

82.04

umol/l

0.69

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

367

2326

1.44

9.61

1.7

1.8

3.71

2.33

ug/l

0.53

295

2000

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

177

2546

0.61

9.36

1.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

179

2565

0.61

9.31

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

847

0.35

9.22

1.5

2.1

2.98

3.28

ratio

1.20

689

(3036481) Cortisol [Moles/volume] in Serum or Plasma

456

3025

1.38

9.21

1.7

2.1

413.29

391.37

nmol/l

0.58

407

2720

(40768443) Skin Pathology biopsy report

112

1797

0.55

9.01

1.2

—

(3032080) INR in Blood by Coagulation assay

2682

21851

1.18

8.98

20.6

22.9

1.41

1.45

inr

2.36

2386

18538

(1001926) Buprenorphine [Presence] in Urine by Screen method

3.71

8.91

1.9

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2353

18977

1.18

8.84

4.0

4.7

33.10

33.72

g/l

5.35

2095

17476

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

410

2.01

8.74

1.6

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

115

2.98

8.63

1.1

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

749

8279

0.79

8.50

2.9

3.6

0.90

0.92

ug/l

0.15

514

6081

(3026493) Urate [Moles/volume] in Serum or Plasma

966

10351

0.81

8.30

2.5

3.1

369.45

373.86

umol/l

0.50

784

8688

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

585

0.26

8.30

1.6

1.8

3.37

3.25

mmol/l

—

431

(3016879) Cocaine [Presence] in Urine

3.33

8.20

1.9

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

101

3.03

7.99

2.9

2.6

26.25

30.55

umol/l

1.32

(3013139) Helicobacter pylori Ag [Presence] in Stool

143

2080

0.61

7.96

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

236

3078

0.68

7.92

6.8

6.9

24.60

24.26

mmol/l

0.82

223

2934

(3008152) Bicarbonate [Moles/volume] in Arterial blood

454

3084

1.35

7.90

4.2

5.9

24.43

24.42

mmol/l

0.02

432

2948

(3027944) Amphetamines [Presence] in Urine

3.22

7.77

1.9

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.22

7.54

2.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.51

7.42

1.2

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3109

29907

0.86

7.38

8.0

7.7

43.43

41.09

mmol/mol

22.70

2728

26940

(3000764) Benzodiazepines [Presence] in Urine

3.14

7.27

2.0

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

155

2153

0.64

7.10

1.9

2.1

10.78

10.83

nmol/l

0.02

126

1822

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.15

7.04

2.1

—

(3027008) Opiates [Presence] in Urine

3.07

7.00

2.0

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3186

30530

0.87

6.96

5.3

5.9

6.41

6.16

mmol/l

11.55

2769

26777

(3018405) Lactate [Moles/volume] in Arterial blood

254

1601

1.44

6.93

2.4

3.5

1.49

1.45

mmol/l

0.18

248

1565

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

932

9860

0.82

6.93

2.5

2.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1140

8781

1.20

6.90

2.8

3.1

2.47

2.48

mmol/l

0.94

989

7625

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

136

2.58

6.89

1.2

—

(3028300) Cannabinoids [Presence] in Urine

3.04

6.87

2.0

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

102

2.82

6.70

5.6

9.71

8.56

mmol/l

1.30

102

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

876

0.46

6.65

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

471

5355

0.77

6.64

1.4

1.5

3.22

2.81

g/l

1.78

273

2946

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

105

1542

0.60

6.16

1.9

2.3

0.00

g/l

0.50

1336

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

428

2994

1.30

6.11

3.1

3.9

2.14

2.10

mmol/l

0.07

296

2189

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1605

12847

1.16

6.08

2.5

3.34

3.18

mg/l

1.30

1338

10943

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1449

0.60

5.92

2.0

2.4

0.00

g/l

-0.00

1333

(3037522) Nuclear Ab [Titer] in Serum

319

3763

0.75

5.91

1.2

1.3

592.68

506.96

titre

0.33

905

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

7.30

5.83

2.0

1.4

19.18

15.45

umol/l

0.50

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

403

4595

0.77

5.81

4.4

5.2

33.68

34.21

0.36

249

2840

(3021589) Normoblasts [#/volume] in Blood

1526

15280

0.86

5.80

14.7

13.1

0.00

e9/l

0.16

1279

12181

(3003181) Sodium [Moles/volume] in Urine

174

1057

1.49

5.80

1.4

1.3

63.90

59.40

mmol/l

0.84

140

834

(3040151) Glucose [Moles/volume] in Capillary blood

116

644

1.63

5.74

5.2

8.6

7.84

7.19

mmol/l

0.88

537

(3005570) Glucose [Moles/volume] in Urine

470

1.73

5.61

2.3

2.1

—

(3052592) Norovirus Ag [Presence] in Stool

2.76

5.48

1.4

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

124

709

1.58

5.46

1.4

0.33

0.29

mg/l

0.24

271

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

316

3685

0.76

5.41

2.4

33.98

39.00

u/l

0.75

258

3056

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2853

23907

1.13

5.39

4.1

4.2

15.39

15.29

pmol/l

1.16

2523

21067

(3016038) Potassium [Moles/volume] in Urine

346

1.82

5.27

1.1

32.26

35.22

mmol/l

0.54

281

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.70

5.27

1.6

1.5

0.24

0.19

mmol/l

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

159

2060

0.68

5.25

2.4

2.5

0.32

0.34

iu/ml

0.35

1165

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

798

6101

1.20

5.17

2.0

1.9

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3776

32249

1.13

5.16

27.2

22.5

30.12

30.16

mg/l

0.03

3493

28315

(40768800) Prostate Pathology biopsy report

976

0.56

5.03

1.1

1.2

—

(3001604) Monocytes [#/volume] in Blood

1868

18302

0.88

5.03

5.1

5.5

0.66

0.65

e9/l

0.47

1620

15186

(3013115) Eosinophils [#/volume] in Blood

1929

18860

0.88

5.02

5.4

5.7

0.20

e9/l

0.25

1653

15917

(3000494) Fungus identified in Specimen by Culture

346

3936

0.78

4.92

1.3

1.4

—

(3003694) ABO and Rh group [Type] in Blood

778

8119

0.84

4.86

1.2

1.3

—

(3009343) pH of Capillary blood

457

3323

1.25

4.83

3.2

4.0

7.41

0.56

402

2801

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

467

3405

1.25

4.82

3.2

4.0

5.17

5.18

kpa

0.05

428

3210

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

483

5264

0.81

4.74

2.5

3.7

14.49

28.96

ug/l

1.05

409

4443

(3006315) Basophils [#/volume] in Blood

1885

18396

0.88

4.68

5.2

5.5

0.04

e9/l

1.13

1630

15297

(40768793) Breast Pathology biopsy report

719

0.52

4.40

1.1

1.3

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.71

4.37

1.1

—

(3018095) Leukocytes [#/volume] in Urine

1873

15448

1.13

4.31

5.0

4.5

176.42

149.64

e6/l

0.46

1467

11479

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

458

0.41

4.30

1.3

1.6

69.76

48.56

nmol/l

1.32

435

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

494

0.43

4.26

1.4

1.7

11.10

4.66

mg/l

0.79

410

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

324

0.30

4.25

1.1

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2234

18636

1.12

4.21

3.6

3.3

58.91

60.42

u/l

0.29

2021

16805

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1310

10580

1.14

4.18

2.7

3.0

34.38

37.10

u/l

0.69

1207

9802

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.64

4.17

1.1

—

(4198724) Urine methamphetamine measurement

5.99

4.09

2.1

1.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

843

6604

1.17

4.09

2.0

1.9

—

(4268621) Lupus anticoagulant assay

209

0.26

4.06

1.8

2.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

263

1829

1.30

4.03

2.7

3.2

24.60

24.88

mmol/l

0.48

254

1794

(3002582) Erythrocytes [#/volume] in Urine

1735

14316

1.12

3.89

4.2

3.8

76.20

122.42

e6/l

1.70

1422

11238

(3013650) Neutrophils [#/volume] in Blood by Automated count

2157

20714

0.90

3.84

7.3

8.5

5.12

4.57

e9/l

11.01

1872

17595

(4094501) Cardiovascular stress test using bicycle ergometer

733

0.56

3.83

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

447

0.44

3.82

1.3

1.5

1.09

0.89

g/l

0.17

348

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1886

15651

1.12

3.81

4.1

3.8

—

3.10

—

(3048689) Calprotectin [Mass/mass] in Stool

284

3196

0.79

3.75

1.8

2.0

232.40

178.20

ug/g

0.74

215

2490

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

154

1882

0.73

3.72

2.4

2.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

118

1506

0.70

3.69

1.2

1.3

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

981

0.63

3.68

2.4

2.1

3.38

3.65

g/l

0.80

921

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2845

24164

1.11

3.67

31.7

30.0

329.31

329.58

g/l

0.80

2784

23880

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

197

0.27

3.63

1.0

1.1

83.17

92.84

—

179

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

856

0.60

3.63

1.2

39.11

42.61

u/l

0.10

730

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

327

1.68

3.60

1.1

60.13

44.62

iu/ml

—

(40768795) Lymph node Pathology biopsy report

346

0.39

3.56

1.1

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

111

1417

0.70

3.50

1.3

201.08

233.80

u/ml

0.36

1301

(3017732) Neutrophils [#/volume] in Blood

381

4117

0.82

3.48

3.4

3.2

5.19

5.18

e9/l

0.01

302

3324

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

452

3410

1.20

3.42

2.0

1.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

129

1596

0.72

3.39

1.9

2.4

0.05

g/l

0.01

109

1410

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

3.34

0.0

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

335

0.40

3.33

1.5

1.7

—

(40768441) Liver Pathology biopsy report

215

0.33

3.32

1.5

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.07

3.24

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

163

1929

0.75

3.22

2.1

2.4

0.69

1.29

g/l

1.79

129

1589

(3023419) Bacteria identified in Sputum by Culture

639

0.57

3.21

1.6

2.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

196

1355

1.31

3.21

2.3

3.1

7.50

7.68

kpa

1.06

188

1319

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

116

2.09

3.15

1.1

1.8

48.36

59.26

ug/l

0.62

110

(3007853) Bacteria identified in Skin by Aerobe culture

615

4802

1.17

3.14

1.9

—

(4034850) Laboratory test

156

1048

1.34

3.12

11.5

14.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.86

3.11

1.1

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

2.86

3.11

2.4

2.8

33.04

38.03

umol/l

0.28

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1800

17299

0.91

3.08

2.8

3.0

—

estimate

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

578

5955

0.86

3.08

1.2

1.56

1.51

u/ml

0.04

147

1397

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1157

11380

0.89

3.06

3.9

5.2

21.56

22.66

1.63

615

6357

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

599

6146

0.86

3.03

2.7

3.6

252.25

250.63

u/l

0.10

544

5729

(1761868) Lipid panel - Serum or Plasma

801

8048

0.88

3.00

3.9

3.8

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

273

3002

0.81

2.99

3.6

3.0

58.11

55.02

ml/min/173m2

0.82

132

1474

(3019069) Monocytes/Leukocytes in Blood

1802

17291

0.91

2.97

5.5

6.0

9.02

9.29

3.01

1651

15932

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

252

0.35

2.94

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

390

0.48

2.94

1.4

1.2

—

(1002224) Polysomnography panel

519

0.55

2.93

1.1

—

(3025941) Bacteria identified in Stool by Culture

232

1664

1.26

2.88

1.3

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.85

2.88

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

263

2886

0.81

2.84

6.4

6.3

24.80

24.83

mmol/l

0.05

254

2851

(3026389) Candida sp identified in Specimen by Organism specific culture

458

1.49

2.83

1.7

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

1958

18679

0.91

2.82

5.5

5.7

1.69

1.85

e9/l

3.15

1716

15939

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.17

2.81

1.1

—

(3006504) Eosinophils/Leukocytes in Blood

1802

17255

0.91

2.81

5.4

5.9

2.73

2.75

0.13

1659

15916

(3018010) Neutrophils/Leukocytes in Blood

1776

17016

0.91

2.80

5.6

5.8

61.94

60.14

7.98

1675

16036

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

198

0.36

2.80

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

475

0.55

2.76

1.4

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

576

4522

1.16

2.76

2.7

2.5

6.45

6.29

ug/l

0.06

432

3791

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1208

0.72

2.73

1.6

1.5

—

(3042631) Mycobacterium sp identified in Specimen

750

0.64

2.70

2.3

2.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.31

2.69

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.25

2.67

1.2

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

866

0.67

2.66

2.3

2.0

52.65

58.03

1.19

861

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

122

1457

0.75

2.63

3.1

4.0

85.61

115.17

u/ml

0.52

115

1387

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

4.84

2.62

1.4

1.0

—

(3022096) Basophils/Leukocytes in Blood

1808

17260

0.91

2.60

5.5

5.9

0.56

0.61

4.02

1650

15934

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

239

2620

0.81

2.59

5.9

7.9

15.55

15.57

0.05

225

2528

(3036489) Thrombin time

1175

0.72

2.58

1.8

20.58

21.70

1.07

1081

(3047181) Lactate [Moles/volume] in Blood

186

1319

1.27

2.58

4.3

5.1

1.41

1.39

mmol/l

0.10

161

1174

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

719

0.65

2.56

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

285

0.44

2.55

1.1

1.2

2.80

5.03

u/ml

—

143

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.09

2.55

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

162

0.33

2.55

1.0

1.2

1.65

1.54

g/l

—

162

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

439

0.55

2.54

3.1

3.2

17.02

8.31

nmol/l

0.41

427

(3039443) Prostate specific Ag panel - Serum or Plasma

308

0.46

2.52

1.3

1.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

304

1.57

2.50

1.6

1.7

9.02

8.26

mmol/l

0.40

304

(3006184) Hemoglobin [Mass/volume] in Capillary blood

178

1263

1.27

2.47

2.1

2.4

123.68

124.17

g/l

0.11

145

975

(3004775) Volume in Urine collected for unspecified duration

363

1.51

2.45

2.1

652.03

628.53

0.15

215

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

943

0.70

2.42

1.6

—

(3021901) Oxygen saturation in Capillary blood

169

1196

1.28

2.40

2.3

3.1

87.96

88.22

0.18

162

1162

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

430

4437

0.86

2.38

2.2

2.5

9.66

10.86

umol/l

0.53

352

3895

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.00

2.34

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

154

1750

0.78

2.33

1.6

2.8

747.22

3954.85

u/ml

1.21

121

1485

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

285

0.47

2.31

1.5

1.7

81.07

118.02

ng/l

2.19

285

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

125

1.87

2.30

1.2

1.1

—

(3002030) Lymphocytes/Leukocytes in Blood

1839

17467

0.92

2.30

5.8

5.9

22.66

24.24

7.63

1720

16305

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

402

0.56

2.29

1.1

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

2.99

2.29

1.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3836

33412

1.08

2.28

31.6

28.1

139.38

139.27

mmol/l

1.42

3688

32591

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

611

0.64

2.25

2.7

3.5

—

(4195642) Thrombophilia screening test

245

0.44

2.24

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3837

33433

1.08

2.24

31.5

28.3

4.02

4.03

mmol/l

1.83

3688

32572

(3052851) Hemolysis interference index of Serum or Plasma

117

1367

0.76

2.21

4.4

3.7

1.96

1.86

index

0.07

728

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.42

2.20

1.5

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.97

2.16

1.1

1.2

93.07

129.51

nmol/l

0.78

(43055442) Apixaban [Mass/volume] in Serum or Plasma

134

0.33

2.16

1.8

1.6

53.60

121.64

ug/l

—

122

(3025130) Human papilloma virus identified in Specimen

149

0.36

2.15

1.2

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

301

0.51

2.15

1.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

881

7225

1.11

2.14

3.8

3.5

3.71

2.47

e6/l

2.27

566

3833

(3008295) Osmolality of Serum or Plasma

481

1.40

2.11

1.3

274.79

273.17

mosm/kgh2o

0.25

340

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.27

2.10

1.0

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

573

4591

1.13

2.09

5.1

4.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.98

2.09

1.0

1.1

1.34

1.23

u/l

—

(3045788) Cell count panel - Pleural fluid

737

0.69

2.07

1.3

1.5

—

(36660697) Celiac disease serology panel - Serum

188

2058

0.81

2.07

1.2

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

0.00

2.06

0.0

2.3

—

1875.53

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2246

19222

1.08

2.06

5.8

6.4

1.21

mmol/l

2.61

2011

17515

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

409

0.59

2.03

1.0

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

972

0.73

2.02

1.7

2.9

79.83

916.22

u/ml

2.10

885

(3044927) Protein electrophoresis panel - Urine

585

1.35

2.01

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.91

2.00

1.4

1.5

15.27

16.51

pmol/l

0.65

(3049717) Cytology report of Urine Cyto stain

204

2196

0.83

1.92

2.5

3.0

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

229

0.47

1.91

1.2

1.1

97.17

101.86

u/l

0.08

193

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

204

0.44

1.90

1.2

1.4

—

(21494815) CD4 cells/Lymphocytes in Specimen

204

0.44

1.90

1.7

40.70

36.12

—

199

(21494434) Karyotype in Bone marrow

412

0.61

1.89

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1154

0.77

1.89

1.5

1.6

10.48

8.69

iu/ml

0.23

260

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3845

33604

1.07

1.89

32.7

30.5

89.51

90.83

umol/l

1.00

3702

32904

(3010813) Leukocytes [#/volume] in Blood

3852

33668

1.07

1.88

36.7

33.6

7.51

7.22

e9/l

8.63

3671

32484

(3026361) Erythrocytes [#/volume] in Blood

3851

33660

1.07

1.88

36.7

33.6

4.15

4.27

e12/l

36.62

3670

32465

(3035941) MCH [Entitic mass]

3851

33660

1.07

1.88

36.6

33.5

30.31

30.40

1.78

3720

32988

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3851

33660

1.07

1.88

37.0

34.1

36.21

38.49

49.83

3717

32954

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

617

0.68

1.88

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

3851

33664

1.07

1.87

37.1

33.9

124.95

128.51

g/l

39.49

3733

33015

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3850

33660

1.07

1.85

36.6

33.5

91.96

92.11

0.98

3721

32987

(3008898) HLA-B27 [Presence]

431

0.62

1.84

1.0

1.1

—

(40768806) Pleura Pathology biopsy report

792

0.72

1.84

1.3

1.6

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.59

1.84

1.5

1.1

—

(4024509) Urine culture

258

1971

1.18

1.83

2.3

2.1

—

(3007461) Platelets [#/volume] in Blood

3849

33657

1.07

1.83

36.7

33.6

240.69

235.50

e9/l

4.21

3688

32627

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

242

2552

0.84

1.82

1.4

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

271

0.53

1.81

1.0

1.3

0.58

0.49

g/l

0.27

207

(3028192) IgG subclass 2 [Mass/volume] in Serum

271

0.53

1.81

1.0

1.3

3.01

2.91

g/l

0.08

211

(3027135) IgG subclass 1 [Mass/volume] in Serum

271

0.53

1.81

1.0

1.3

7.89

6.77

g/l

0.39

207

(3047189) Immunofixation for 24 hour Urine

247

0.51

1.80

1.1

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

171

1.63

1.79

1.3

1.32

1.03

nmol/l

0.92

121

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3342

29097

1.07

1.79

5.3

5.4

2.13

2.14

mu/l

0.08

2970

25859

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

449

0.64

1.78

1.0

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

858

0.74

1.77

1.3

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

425

0.63

1.75

1.4

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.99

1.74

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

232

0.50

1.74

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

266

0.54

1.72

1.9

2.1

4.17

3.60

ug/l

0.20

245

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

289

0.56

1.72

1.2

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.93

1.71

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

160

0.45

1.70

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

821

0.74

1.70

1.2

4.75

32.13

u/ml

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

113

1.75

1.65

1.0

1.1

22.17

451.29

ng/l

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

764

0.74

1.63

1.1

1.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

119

0.38

1.63

1.6

1.2

—

(4062490) Immunoglobulin typing, IgG

270

0.56

1.58

1.1

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

332

1.41

1.57

2.8

3.2

57.08

38.71

mg/l

0.23

255

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

687

0.73

1.57

1.2

1.10

6.16

u/ml

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

292

0.58

1.57

1.1

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

347

0.62

1.56

1.5

1.3

8.82

10.75

u/l

0.31

266

(3024928) Oxygen saturation in Venous blood

101

1140

0.79

1.55

2.0

2.3

51.45

57.33

1.92

1069

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

196

2070

0.84

1.55

2.2

2.3

2.82

3.03

g/l

1.99

164

1805

(3020779) Urea [Moles/volume] in Serum or Plasma

471

4681

0.89

1.54

4.4

5.8

13.14

12.86

mmol/l

0.25

432

4375

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

281

2885

0.87

1.54

2.8

3.3

24.18

24.05

mmol/l

0.29

274

2816

(3016650) Hepatitis A virus Ab [Presence] in Serum

379

1.38

1.54

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

279

0.58

1.54

1.2

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1089

0.79

1.54

1.0

1.1

—

182.68

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

653

0.73

1.53

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

1.89

1.53

1.1

—

(3037121) Protein [Mass/volume] in Urine

208

1589

1.18

1.53

2.6

2.8

248.60

551.95

mg/l

1.52

656

(3012441) Differential panel - Pleural fluid

796

0.75

1.53

1.3

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

825

0.76

1.51

1.2

1.4

17020.31

56894.53

e6/l

3.25

489

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

784

0.75

1.51

1.2

2.24

7.22

u/ml

—

(44806420) Estimation of glomerular filtration rate

260

1.45

1.51

2.5

2.6

—

(3009871) Measles virus Ab [Titer] in Serum

0.00

1.50

0.0

1.6

—

3640.00

—

(3017569) Oxygen content in Arterial blood

321

1.40

1.48

1.9

16.63

15.52

1.58

321

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

230

0.55

1.48

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

460

0.68

1.47

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

190

2002

0.85

1.47

2.0

2.3

10.22

10.56

g/l

0.40

155

1717

(3028026) IgM [Mass/volume] in Serum or Plasma

189

1992

0.85

1.47

1.4

1.8

1.00

1.44

g/l

4.25

162

1760

(3023199) Leukocytes [#/volume] in Pleural fluid

930

0.78

1.45

1.3

1.5

1725.02

2432.90

e6/l

0.28

677

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3191

27854

1.06

1.44

6.6

8.3

87.53

86.50

u/l

0.33

2956

26126

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

788

0.76

1.44

1.2

4.19

5.43

u/ml

0.31

123

(3000475) Leukocytes [#/volume] in Synovial fluid

1068

0.79

1.43

1.5

14172.06

17719.09

e6/l

0.63

736

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1008

0.79

1.43

1.2

0.49

0.64

u/ml

0.21

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

204

0.53

1.42

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

218

1685

1.17

1.41

2.3

2.5

51.92

20.61

au/ml

—

(3000012) Reticulocyte production index

123

902

1.23

1.41

2.4

2.0

0.93

0.87

0.59

641

(4281824) Cell count and differential, peritoneal fluid

391

0.66

1.40

1.1

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

309

3128

0.88

1.40

5.7

7.3

1.44

1.29

2.86

301

3099

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

191

0.52

1.40

1.2

1.8

19.45

18.01

0.15

181

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2677

24765

0.95

1.37

30.8

27.9

14.29

14.22

1.88

2610

24332

(3022313) Gas panel - Capillary blood

294

2329

1.14

1.37

3.4

4.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

0.00

1.35

0.0

2.6

—

1.22

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

136

1014

1.21

1.34

2.1

2.3

86.45

95.13

ug/min

0.11

582

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

102

1128

0.81

1.34

2.4

1.93

1.94

mg/l

0.06

961

(3020630) Protein [Mass/volume] in Serum or Plasma

469

4621

0.90

1.34

2.0

2.5

64.74

65.58

g/l

1.45

394

4095

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

244

0.59

1.32

1.1

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

212

1647

1.16

1.31

2.3

3.1

4.16

4.29

pmol/l

1.04

178

1399

(3032057) Clostridioides difficile [Presence] in Stool

122

1.62

1.30

1.4

1.7

—

(3028717) Thiamine [Mass/volume] in Blood

2.39

1.30

1.3

1.2

73.50

61.97

ug/l

—

(3003434) Protein [Mass/volume] in Pleural fluid

1072

0.81

1.28

1.4

1.5

30.28

29.64

g/l

0.19

957

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

873

0.79

1.28

1.2

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

317

2537

1.13

1.27

2.6

—

(3019225) pH of Specimen

522

4296

1.10

1.26

5.3

4.8

7.38

7.36

0.71

375

3088

(3018572) Chloride [Moles/volume] in Blood

120

891

1.21

1.25

4.6

5.8

105.01

104.69

mmol/l

0.30

109

795

(3039000) Anion gap in Blood by calculation

120

891

1.21

1.25

4.6

5.7

11.10

11.40

mmol/l

0.36

109

794

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

619

0.75

1.25

1.1

1.4

—

14.91

u/ml

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

194

0.55

1.24

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.02

1.24

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

357

1.33

1.22

1.1

1.4

23.88

30.34

ng/l

0.73

357

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

303

3039

0.89

1.22

5.8

7.5

0.73

0.63

4.04

297

3014

(1616796) Gas panel - Central venous blood

156

1192

1.18

1.20

2.9

4.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

834

0.79

1.19

1.3

1.7

10.98

12.97

mg/l

1.16

752

(40767503) Oxygen content in Capillary blood by calculation

142

1080

1.18

1.17

2.6

2.7

15.54

15.57

0.04

134

1060

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

1.14

0.0

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

659

0.77

1.13

1.1

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1521

14229

0.95

1.13

4.5

6.4

4.93

5.96

ug/l

0.28

1318

12472

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.86

1.13

1.3

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

828

0.80

1.13

1.8

1.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

188

0.57

1.13

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

188

0.57

1.13

1.2

—

(36304419) Bacteria [Presence] in Urine

1233

11601

0.94

1.12

4.0

3.7

0.00

275.97

estimate

0.90

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

176

0.56

1.11

1.0

1.1

—

(4015189) Microbial culture of sputum

126

0.50

1.09

2.9

2.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

222

2250

0.88

1.08

2.1

2.3

3.63

3.66

g/l

0.10

192

1988

(3034770) Mitochondria Ab [Titer] in Serum

774

0.80

1.08

1.1

—

1011.00

—

(3043410) Blood group antigens tested for on Red Blood Cells

158

1.48

1.08

1.4

2.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

773

0.80

1.07

1.2

1.5

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

185

0.58

1.07

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

185

0.58

1.07

1.2

1.6

37.40

39.39

g/l

0.59

185

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1048

0.83

1.07

1.6

69.78

32.72

u/ml

1.13

164

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.17

1.07

2.0

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

137

1.51

1.05

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.86

1.05

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.62

1.05

2.0

2.3

528.80

334.02

mu/l

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

760

0.80

1.04

1.2

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

130

1.52

1.04

1.0

1.2

8.66

17.32

pmol/l

—

(21494890) Protein electrophoresis panel - 24 hour Urine

538

0.77

1.02

1.4

1.8

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1.74

1.02

7.0

13.80

13.82

0.02

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

224

1785

1.13

1.02

3.7

4.4

24.96

24.79

mmol/l

0.31

195

1596

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

855

0.82

1.01

1.5

1.99

9.08

iu/ml

0.56

209

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

181

0.59

1.00

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.83

1.00

1.5

1.7

1.93

0.92

ug/l

0.40

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

224

2254

0.89

0.99

2.1

2.3

4.32

4.15

g/l

1.35

192

1995

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2404

20976

1.05

0.99

4.7

6.1

12.26

13.20

umol/l

2.57

2258

19923

(3018677) aPTT in Platelet poor plasma by Coagulation assay

808

6844

1.07

0.99

2.0

1.9

29.46

30.36

3.45

778

6625

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.98

0.0

1.0

—

(3000991) Gas panel - Venous blood

442

4291

0.92

0.98

5.3

6.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.64

0.97

1.1

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

246

1.35

0.97

1.9

1.00

3.14

u/field

2.01

155

(3018333) Ribosomal P Ab [Presence] in Serum

179

0.60

0.96

1.2

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.95

0.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.80

0.95

1.4

1.1

—

(40761536) Microorganisms panel - Urine sediment

306

3017

0.91

0.95

5.7

4.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

275

0.68

0.95

1.1

—

2.26

—

(3035933) Granulocytes/Leukocytes in Blood

740

0.81

0.95

3.2

3.0

57.87

60.34

0.58

740

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

225

2255

0.89

0.95

2.1

2.3

7.69

7.52

g/l

0.70

193

1992

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

155

1213

1.15

0.94

1.5

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

155

1213

1.15

0.94

1.5

1.4

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.90

0.94

11.3

12.6

0.21

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.90

0.94

1.0

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

188

1493

1.13

0.92

1.3

38.91

61.51

au/ml

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

154

0.58

0.91

1.0

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

799

7565

0.94

0.91

2.5

2.7

19.67

20.39

0.63

705

6938

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

128

1326

0.86

0.90

1.1

217.34

121.02

u/ml

0.41

432

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

175

0.61

0.90

1.2

1.1

0.26

0.85

u/ml

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.48

0.89

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

114

0.55

0.88

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

196

0.64

0.88

1.4

1.8

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

116

0.54

0.88

2.1

1.4

9.17

16.63

ug/l

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

205

1.36

0.86

1.7

1.9

107.94

109.37

umol/l

0.03

205

(3004809) Band form neutrophils/Leukocytes in Blood

115

889

1.16

0.84

3.0

3.9

0.94

1.55

1.98

763

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

469

1.23

0.84

1.7

27.95

28.07

u/ml

0.01

107

(3051611) Lipemic interference index of Serum or Plasma

491

0.78

0.84

4.0

3.4

12.20

11.95

index

0.08

265

(3037692) Legionella sp identified in Specimen by Organism specific culture

125

0.57

0.83

1.1

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

125

0.57

0.83

3.1

2.1

0.62

0.61

mmol/l

—

125

(3008757) Leukocyte morphology finding [Identifier] in Blood

530

0.79

0.83

2.7

4.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

766

0.83

1.2

1.1

52.86

100.60

titre

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1056

9074

1.05

0.82

5.4

4.3

0.08

0.38

0.49

165

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.70

0.82

2.3

2.7

0.55

0.31

u/field

0.51

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

266

0.71

0.82

1.0

1.1

—

1.31

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

144

1467

0.88

0.82

1.3

1.2

—

(3028433) Virus identified in Specimen by Culture

101

1.51

0.82

1.1

—

(3024263) Appearance of Synovial fluid

234

0.69

0.81

1.7

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

446

3732

1.08

0.80

3.2

3.6

94.18

103.47

ng/l

1.23

348

3097

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

387

0.76

0.80

1.2

1.3

0.20

0.21

nmol/l

0.25

310

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.79

0.0

1.0

—

123.64

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.79

0.0

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.79

0.0

1.1

—

10.77

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1953

17039

1.04

0.79

3.4

3.7

2418.22

2442.72

ng/l

0.07

1674

15044

(3045424) Erythrocytes [Presence] in Urine

182

1821

0.89

0.78

2.0

2.1

0.00

0.58

estimate

0.51

438

(3047007) Chlamydophila sp Ab [Presence] in Serum

253

0.71

0.78

1.2

—

(3006969) Lambda light chains [Mass/volume] in Urine

0.00

0.78

0.0

1.0

—

0.03

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

284

0.73

0.78

1.9

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

284

0.73

0.78

1.9

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

325

0.74

0.78

1.1

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

231

2280

0.91

0.77

1.4

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.77

0.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

0.00

0.77

0.0

1.1

—

0.14

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

354

0.76

1.4

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.72

0.76

1.0

1.2

—

3875.00

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

108

1114

0.87

0.75

1.1

—

(3006462) Nitrate [Presence] in Urine

187

1.34

0.75

6.8

4.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

145

0.62

0.75

5.4

6.6

9.58

242.66

ug/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

329

2730

1.09

0.75

1.4

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

301

0.74

2.8

3.6

—

(40757373) Influenza virus identified in Isolate

104

1.47

0.73

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.55

0.72

1.2

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.62

0.72

1.1

2.64

2.16

umol/l

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

364

1.23

0.72

1.2

1.3

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

154

0.64

0.72

1.4

10.08

19.51

umol/l

4.24

136

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

413

1.22

0.72

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.75

0.71

1.3

1.0

—

(3004451) EKG impression Narrative

339

0.77

0.70

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.47

0.69

3.2

2.4

5.94

388.39

ug/l

0.71

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

105

1075

0.87

0.68

1.2

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

574

0.83

0.68

1.2

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

107

0.59

0.68

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

525

0.82

0.68

1.2

22.56

49.13

u/ml

—

(40762887) Creatinine [Moles/volume] in Blood

1.65

0.67

2.0

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

790

6779

1.05

0.67

4.1

4.6

—

(3044007) Cell count panel - Peritoneal fluid

140

0.64

0.66

1.9

1.8

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.50

0.66

1.0

1.3

1.19

1.17

mmol/l

0.35

(3014111) Lactate [Moles/volume] in Serum or Plasma

523

4438

1.06

0.66

4.5

5.7

1.61

1.45

mmol/l

1.61

504

4299

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.79

0.66

1.6

5.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

369

1.22

0.65

1.2

1.3

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

453

0.81

0.64

1.1

—

9.93

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.54

0.64

1.1

—

16.13

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

170

0.69

0.63

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

170

0.69

0.63

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

118

0.61

0.63

1.1

1.4

29.75

29.25

umol/l

—

107

(3027945) Reticulocytes/Erythrocytes in Blood

779

6696

1.05

0.63

2.1

2.3

1.81

1.78

0.39

655

5830

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

501

4746

0.94

0.63

3.3

3.4

322.06

325.39

ng/l

0.03

454

4344

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

655

0.85

0.62

2.4

2.3

26.64

26.27

mg/l

0.02

226

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

137

0.65

0.61

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

211

1737

1.09

0.61

3.4

3.3

0.89

0.84

nmol/l

0.47

159

1381

(3016502) Oxygen saturation in Arterial blood

608

5198

1.05

0.61

4.6

6.0

94.31

94.82

0.95

581

4983

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.61

0.0

4.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

209

2039

0.92

0.59

2.1

3.0

38.75

60.94

mg/l

1.66

171

1728

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

293

1.23

0.58

1.3

1.2

0.99

1.53

nmol/l

2.73

256

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.57

0.56

1.0

—

2.13

—

(3018418) pH of Serum or Plasma

1473

12870

1.04

0.56

3.5

4.2

7.40

3.17

1092

9402

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

551

0.85

0.56

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

107

855

1.12

0.56

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.52

0.55

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

112

0.64

0.54

1.3

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

461

1.17

0.54

3.5

3.0

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

231

1.24

0.54

1.0

1.2

—

213.42

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

372

0.82

0.52

1.2

1.3

—

nmol/l

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

120

0.67

0.52

1.1

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

303

2892

0.94

0.51

1.5

1.6

1.71

1.53

g/l

2.48

250

2459

(3034860) Kappa light chains.free [Mass/volume] in Serum

212

2046

0.93

0.50

2.0

3.0

67.44

90.87

mg/l

0.38

172

1733

(40768446) Kidney Pathology biopsy report

1.44

0.49

1.1

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

201

0.76

0.49

1.1

1.5

63.87

67.24

mg/l

—

131

(3036782) Glucose [Moles/volume] in Pleural fluid

696

0.88

0.49

1.3

1.4

5.89

6.46

mmol/l

1.09

652

(4211845) Urine protein measurement

202

1.24

0.48

6.8

4.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

368

0.83

0.48

1.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

873

0.89

0.47

1.4

1.11

1.15

g/l

0.50

824

(3008536) Aspergillus sp Ab [Presence] in Serum

0.61

0.46

1.2

1.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.37

0.45

1.4

1.2

34.78

89.75

u/l

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1758

16086

0.97

0.45

3.0

3.2

165.21

157.80

ug/l

0.49

1547

14464

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

851

0.89

0.44

1.3

1.4

0.23

g/l

0.12

801

(3017704) Immunofixation for Urine

280

1.19

0.42

1.2

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

133

1297

0.92

0.42

1.3

1.7

37.82

38.78

u/l

0.17

108

1078

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

110

1081

0.91

0.42

1.2

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

116

1137

0.91

0.42

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

352

0.84

0.42

1.2

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

352

0.84

0.42

1.2

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

352

0.84

0.42

1.2

1.4

—

(3022229) Phosphate [Moles/volume] in Urine

0.00

0.41

0.0

1.0

—

16.39

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

165

0.76

0.41

1.2

1.1

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

0.00

0.41

0.0

1.2

—

0.11

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

538

4647

1.04

0.40

4.9

6.6

119.55

118.02

g/l

1.02

523

4531

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

389

0.85

0.40

1.1

1.3

168.00

158.35

au/ml

—

114

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

391

1.15

0.40

1.1

1.4

822.50

312.09

titre

0.60

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

249

1.19

0.40

1.1

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

249

1.19

0.40

1.1

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.69

0.39

1.0

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.39

0.0

1.0

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

163

0.77

0.38

1.2

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

528

1.12

0.38

1.3

1.4

—

(3037756) Immunofixation for Serum or Plasma

125

1214

0.92

0.38

1.3

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3629

32854

0.98

0.38

10.9

13.2

21.97

23.36

u/l

2.46

3417

31417

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

212

0.80

0.38

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

101

0.71

0.37

1.5

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

109

1062

0.92

0.36

1.3

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

690

6379

0.97

0.36

4.0

5.1

1.04

1.06

mmol/l

0.76

608

5792

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

659

0.90

0.36

1.2

—

(3017181) Myelocytes/Leukocytes in Blood

417

3597

1.04

0.35

3.5

3.9

0.91

0.95

0.11

149

1265

(3021440) Promyelocytes/Leukocytes in Blood

400

3450

1.04

0.34

3.4

3.9

0.06

0.11

1.14

133

1118

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.69

0.33

1.8

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

145

1389

0.94

0.33

1.5

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

262

2464

0.95

0.32

1.9

2.8

10.64

11.01

g/l

0.61

234

2223

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

197

1.18

0.32

1.1

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

158

0.79

0.31

1.1

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

158

0.79

0.31

1.1

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

197

0.82

0.31

1.3

1.2

87.61

296.60

u/l

2.32

184

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

303

0.86

0.31

1.9

1.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

878

8062

0.97

0.31

2.3

2.6

2.18

2.22

g/l

1.02

778

7343

(37208534) Antinuclear antibody arbitrary concentration in serum

0.72

0.31

1.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

463

0.89

0.30

1.5

70.67

63.98

0.60

297

(3010421) pH of Blood

181

1537

1.06

0.30

3.6

4.1

7.41

0.28

171

1506

(3000570) Elastase.pancreatic [Mass/mass] in Stool

139

1172

1.07

0.29

1.4

278.70

258.42

ug/g

0.57

738

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

334

1.13

0.29

1.1

1.2

—

(3020650) Glucose [Presence] in Urine

0.72

0.29

1.8

1.7

0.00

0.03

estimate

—

(3002523) Influenza virus A Ag [Presence] in Specimen

175

0.82

0.28

1.2

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

158

1.19

0.28

2.7

2.2

4.87

4.94

kpa

0.14

158

(3042936) Bacteria identified in Isolate by Culture

697

6101

1.03

0.28

2.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

175

1.18

0.27

1.0

1.1

—

(3025159) Blasts/Leukocytes in Blood

362

3363

0.96

0.27

3.5

4.1

0.51

0.14

0.48

103

1000

(3042010) Triglyceride [Moles/volume] in Pleural fluid

101

1.24

0.27

1.4

1.2

0.26

1.48

mmol/l

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

159

1.19

0.27

2.7

2.2

10.27

10.29

kpa

0.01

159

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2853

25371

1.02

0.26

4.0

4.6

18.19

16.83

mm/h

3.17

2560

23138

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.27

0.26

1.1

—

(3022689) Creatine [Moles/volume] in Urine

1.27

0.26

1.3

1.4

7.32

6.67

mmol/l

0.26

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

199

1870

0.95

0.26

2.1

2.9

3.46

4.82

ratio

0.41

139

1161

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.67

0.26

1.0

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

985

9004

0.98

0.26

5.0

4.8

175.42

533.35

ng/l

2.95

857

8169

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.30

0.26

3.1

2.2

0.84

0.68

ug/l

—

(3012501) Base excess in Blood by calculation

123

1040

1.06

0.25

4.4

4.7

2.40

3.01

mmol/l

1.39

700

(4146454) Self-monitoring of blood glucose

503

0.91

0.25

2.4

2.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

814

1.07

0.25

1.3

1.2

237.50

254.49

titre

—

(3013290) Carbon dioxide [Partial pressure] in Blood

123

1041

1.06

0.24

4.4

4.7

4.92

5.07

kpa

1.09

113

1003

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

455

0.91

0.24

1.1

1.2

—

21.89

—

(3023383) Lactate [Moles/volume] in Pleural fluid

220

1.14

0.24

1.4

1.3

2.97

3.44

mmol/l

0.35

199

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

0.70

0.24

1.2

2.5

239.33

217.97

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

705

0.93

0.23

1.2

1.4

629.86

348.26

u/l

0.61

668

(3027315) Oxygen [Partial pressure] in Blood

123

1044

1.06

0.23

4.4

4.7

8.08

8.23

kpa

0.44

112

1006

(3030467) Casts [#/volume] in Urine by Automated count

1404

12426

1.02

0.23

3.9

3.7

0.65

0.58

e6/l

0.40

1156

9525

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

0.76

0.22

1.0

1.8

29.71

30.42

—

(3016750) Collection duration of Urine

247

1.13

0.22

2.0

503.22

500.04

min

0.07

170

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

459

4012

1.03

0.22

1.9

2.0

0.18

0.19

g/l

0.72

395

3665

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.21

0.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

0.08

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.21

0.0

2.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.21

0.0

2.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

602

1.07

0.21

1.9

2.1

1.00

1.11

g/24h

0.15

335

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.76

0.21

1.1

1.5

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.4

—

16.35

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

130

1.17

0.20

1.4

1.2

1.39

1.34

mmol/l

0.05

(3032773) Endomysium IgG Ab [Titer] in Serum

253

0.89

0.20

1.0

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

897

7920

1.02

0.20

1.7

1.6

1.46

1.73

mg/l

2.41

734

6260

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.25

0.19

1.2

1.0

1494.50

1428.18

miu/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

177

0.86

0.19

1.1

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

133

1139

1.05

0.19

1.3

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

156

1.15

0.19

1.3

1.4

12.23

22.76

1.17

128

(3003329) Lymphocytes/Leukocytes in Synovial fluid

364

0.91

0.19

1.5

1.4

21.08

25.67

0.47

230

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.16

0.17

2.6

5.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

175

0.87

0.17

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

222

0.89

0.17

1.2

1.5

9.82

7.46

u/l

0.24

182

(3022948) Iron [Moles/volume] in Serum or Plasma

940

8551

0.98

0.17

2.4

2.7

10.57

11.23

umol/l

1.56

830

7846

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.75

0.17

2.2

1.7

11.66

9.72

ug/l

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.72

0.17

1.2

102.60

111.25

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

146

0.86

0.17

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

146

0.86

0.17

1.1

1.0

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.75

0.15

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

524

1.06

0.15

1.3

1.4

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

285

0.91

0.15

1.4

1.5

65.18

68.99

0.20

235

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

257

0.91

0.15

1.0

1.2

50.00

157.33

titre

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.09

0.14

1.3

1.1

—

(3006245) CD3-CD19+ cells/cells in Blood

0.78

0.14

1.0

1.8

12.29

8.87

—

(3000093) Morphology [Interpretation] in Blood Narrative

496

0.94

0.14

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

209

0.90

0.14

2.8

2.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

509

1.06

0.14

1.3

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

141

1308

0.97

0.13

1.5

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

510

1.06

0.13

1.3

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

402

0.94

0.13

1.3

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

512

1.05

0.12

1.3

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

455

0.95

0.11

1.1

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

399

1.06

0.11

1.2

1.3

295491.03

193346.97

e6/l

0.27

268

(3020491) Glucose [Moles/volume] in Blood

268

1.07

0.11

1.7

2.7

7.71

7.19

mmol/l

0.28

173

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

129

1.11

0.10

1.4

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

383

1.05

0.10

1.2

275.95

249.37

pmol/l

0.27

314

(3011985) Renin [Units/volume] in Plasma

416

0.95

0.10

1.2

1.3

81.01

55.36

mu/l

0.28

361

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

214

0.92

0.10

1.2

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

214

0.92

0.10

1.2

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

214

0.92

0.10

1.2

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

213

0.93

0.09

1.2

1.4

—

(4212803) Bone marrow aspirate examination

1.06

0.08

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.04

0.08

1.3

1.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.77

0.08

1.2

3.7

39.00

73.60

u/l

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.14

0.08

1.5

1.4

81.90

165.05

nmol/24h

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

367

0.95

0.08

1.0

1.1

295.72

319.50

u/ml

0.18

204

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

581

1.03

0.07

1.2

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.80

0.07

1.5

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

387

1.04

0.07

1.1

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

520

1.04

0.07

1.3

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.08

0.07

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

102

936

0.98

0.06

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

528

0.97

0.06

1.7

1.6

4.12

4.17

mmol/24h

0.04

439

(44790049) Parainfluenza type 3 nucleic acid detection

455

0.97

0.06

1.1

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

455

0.97

0.06

1.1

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

455

0.97

0.06

1.1

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

691

1.03

0.06

1.4

1.7

3.51

3.61

iu/l

0.06

231

(3023520) Reticulocytes [#/volume] in Blood

572

5170

0.99

0.06

2.5

2.4

65.20

66.46

e9/l

0.39

455

3833

(3013166) Neutrophils/Leukocytes in Synovial fluid

127

0.92

0.06

1.2

1.3

70.13

64.85

0.29

109

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

218

0.95

0.05

1.3

1007.71

204.13

ug/l

0.36

115

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

454

0.97

0.05

1.1

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

102

933

0.98

0.05

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

523

4722

0.99

0.04

11.3

9.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

596

1.02

0.04

4.7

5.7

12.85

12.68

mg/l

0.11

540

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

552

0.97

0.04

1.3

13.30

12.14

u/l

0.18

501

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.09

0.04

1.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

479

0.97

0.04

1.1

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

241

1.04

0.04

1.9

3.3

0.71

1.16

1.36

241

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

206

1.05

0.03

1.0

—

(3017354) Segmented neutrophils/Leukocytes in Blood

577

0.98

0.03

2.8

3.9

58.49

59.57

0.13

480

(3045414) Leukocytes [Presence] in Urine

420

3747

1.01

0.03

2.4

2.2

0.00

0.02

estimate

1.06

650

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

296

1.03

0.03

1.2

99.00

103.04

pmol/l

0.14

296

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

160

0.95

0.02

4.2

7.5

65.67

74.93

—

124

(3012095) Magnesium [Moles/volume] in Serum or Plasma

800

7198

1.00

0.02

2.3

2.7

0.81

0.82

mmol/l

1.19

716

6614

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

862

7716

1.00

0.02

3.5

3.4

2.39

1.29

e6/l

1.34

544

4325

(3019977) pH of Arterial blood

656

5901

1.00

0.02

4.7

5.9

7.41

7.42

0.37

446

3287

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.93

0.01

1.2

1.1

—

23.68

—

(3044640) Blood type and Crossmatch panel - Blood

1458

13099

1.00

0.01

2.6

2.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

105

0.94

0.01

1.5

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

477

1.02

0.01

1.4

1.5

11.90

14.03

u/l

2.79

455

(3003396) Base excess in Arterial blood by calculation

658

5893

1.00

0.01

4.6

5.9

1.70

0.95

mmol/l

5.12

506

4715

(3000850) Epithelial cells [#/volume] in Urine

1136

10203

1.00

0.01

3.3

2.9

5.95

5.06

e6/l

2.03

1074

9248

(3036670) Protein [Mass/volume] in Synovial fluid

149

0.96

0.00

1.4

1.2

36.88

39.80

g/l

—

(3014891) Appearance of Pleural fluid

140

0.96

0.00

1.7

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

105

1.03

0.00

1.5

1.6

2.40

9.48

nmol/l

1.03

(3035880) pH of Pleural fluid

379

0.99

0.00

1.2

1.3

7.44

7.42

0.26

275

(3002079) Sodium [Moles/time] in 24 hour Urine

111

0.97

0.00

1.0

1.2

197.75

156.56

mmol/24h

0.40

111

(3027801) Oxygen [Partial pressure] in Arterial blood

659

5910

1.00

0.00

4.6

5.9

10.71

11.47

kpa

4.52

622

5593

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

659

5911

1.00

0.00

4.6

5.9

5.08

5.05

kpa

0.28

622

5590

(3014148) Varicella zoster virus Ab [Titer] in Serum

163

0.99

0.00

1.1

—

(3002179) Metamyelocytes/Leukocytes in Blood

376

3371

1.00

0.00

3.3

3.8

0.63

0.68

0.15

134

1164

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

103

923

1.00

0.00

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

110

0.98

0.00

1.0

1.1

2.30

3.63

u/l

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

371

0.99

0.00

1.1

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.92

0.00

1.0

2.0

1.94

2.62

ratio

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

24.85

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

10.37

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.0

—

7.66

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.7

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.9

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

-0.00

0.0

2.0

—

0.16

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1275.71

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.85

-0.00

1.0

1.5

51.20

51.04

umol/l

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.97

-0.00

1.1

1.2

0.35

0.31

g/l

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

-0.00

0.0

1.1

—

0.50

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.95

-0.00

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.85

-0.00

1.2

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

2.40

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

919.26

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

0.17

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.2

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

2.34

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.2

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

4.75

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3018133) Calcium [Moles/volume] in Urine

0.98

-0.00

1.0

1.7

4.00

2.62

mmol/l

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

0.24

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_DEMNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_DEMNAS	2.559 [2.31, 2.83]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.251

During the follow-up period (1.1.1998 — 31.12.2019), 43463 out of 54705 females with F5_DEMNAS died.

Males

Parameter	HR [95% CI]	p-value
F5_DEMNAS	3.239 [2.81, 3.74]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 25233 out of 31895 males with F5_DEMNAS died.

Mortality risk

Mortality risk for people of age

years, who have F5_DEMNAS.

N-year risk	Females	Males
1	0.193%	0.486%
5	1.228%	3.248%
10	3.406%	8.029%
15	6.919%	13.615%
20	11.949%	21.653%

Relationships between endpoints

↥

Index endpoint: F5_DEMNAS – Unspecified dementia

GWS hits: 5

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Unspecified dementia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints